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Our genetic material is intricately folded and protected through the formation of a
compact nucleoprotein complex, termed heterochromatin. In addition to controlling
the expression of genes, heterochromatin formation is important for the structural in-
tegrity of our genome, specifically for the centromeres, the central attachment point
of our chromosomes, and also the telomeres, the ends of our chromosomes. The way
in which the heterochromatin in these areas is formed and maintained is though the
recruitment and binding of the pivotal chromatin regulator, Heterochromatin Protein
1α (HP1α). The current model that explains how and why HP1α is recruited to, and
maintained at, regions of constitutive heterochromatin is simple: HP1α binds post-
translational modifications on histones (eg. H3K9me3). However, this binding is not
high affinity, therefore may not be the sole determinant in HP1α localisation. At the
centromeres, it has been shown that a long non-coding RNA transcribed from the peri-
centromeres is responsible for recruiting HP1α to this crucial region. At the telomeres,
it is proposed that the long non-coding RNA transcribed from the telomeric DNA
is responsible for this same purpose. Because of its guanine-rich sequence, it is able
to form a non-canonical nucleic acid structure, the G-quadruplex, which may provide
the specificity for heterochromatin formation at telomeres. This TElomeric Repeat-
containing RNA (TERRA) has been implicated in telomeric elongation pathways, re-
lating it to the immortalisation of cancer cells. It was found that HP1α can specifically
recognise the parallel topology of TERRA, binding with high affinity through HP1α’s
unstructured hinge. HP1α was also shown to bind other G-quadruplexes of parallel
topology, specifically DNA present in promoter and regulatory regions of many proto-
oncogenes, implicating HP1α in potential G-quadruplex-dependent gene expression reg-
ulatory mechanisms. The interaction shown here between HP1α and TERRA shows
a novel mechanism of telomeric heterochromatin formation, providing crucial insights
into telomere maintenance and health in human cells, and furthering our understanding
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The molecule of life was discovered by accident in the mid-nineteenth century.
Termed ”nuclein”, the scientific community was skeptical that something so seem-
ingly simple compared with complex proteins could be the elusive inherited ma-
terial (Miescher, 1869). Many years after this discovery, microscopy and staining
techniques had advanced dramatically, allowing for the visualisation of the nu-
clear inherited material. Due to the stain and shape of the material, in 1888
the name ”chromosome” was used to describe the unique structures of nuclein
formed in nuclei (in Greek: chromos for colour, soma for body, Rowley (1991)).
Alongside this, the five bases of nucleic acid (adenine (A), cytosine (C), gua-
nine (G), thymine (T), and uracil (U)) were discovered (Levene and Bass, 1931),
Mendelian genetics arose (Mendel, 1865), and finally, the double-helix structure
of deoxyribonucleic acid (DNA) was proposed (Watson et al., 1953).
Watson and Crick elucidated the DNA helix structure, famously stating:
”It has not escaped our notice that the specific pairing we have pos-
tulated immediately suggests a possible copying mechanism for the
genetic material.”
This anti-parallel pairing of phosphate diester groups joining β-D-deoxyribofuranose,
with hydrogen bonded bases in the centre of the helix was revolutionary. In the
canonical double-helix structure of B-DNA described by Watson and Crick, ade-
nine is paired with thymine, and guanine is paired with cytosine.
However, more than 60 years later, we are only now finding out about the plethora
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of non-canonical nucleic acid structures formed in the cell.
1.1 Non-canonical nucleic acid structures
DNA sequences, specifically those of repetitive nature, can adopt a vast number
of alternative structures that do not conform to typical B-DNA. These include
guanine-quadruplexes (G4), intercalated (i)-motifs, triplexes, hairpins, Holliday
junctions, and DNA:RNA hybrids, where nucleotides may not pair in a typical
Watson-Crick manner (Wang and Vasquez, 2014). Greater than half of the hu-
man genome is comprised of repetitive DNA sequences capable of forming these
non-B-DNA structures, as well as RNA transcribed from these repetitive regions
(Consortium et al., 2001). DNA is most likely to form these structures during
replication or transcription, where DNA strands are no longer confined in the
duplex. Due to its single-stranded nature, RNA is particularly inclined to form
non-canonical nucleic acid structures, which have roles in regulation as long non-
coding RNA (lncRNA).
1.1.1 G-quadruplexes
A G4 is formed when four guanine nucleobases hydrogen bond together to form
a tetrad. These tetrads can then stack on top of one another forming a tetraplex
structure. G4s and other non-canonical structures form through Hoogsteen base-
pairing, which is the bonding of the atoms in bases that do not typically form
hydrogen bonds in Watson-Crick base-pairing. Given the oxygen-rich centre of
the G-tetrad, monovalent cations such as K+ are required to stabilise G4s (Burge
et al., 2006).
In vitro, G4s have been shown to be more thermodynamically stable, and slower
to unfold than their DNA or RNA hairpin counterparts (Lane et al., 2008). DNA
and RNA G4s have numerous possible conformations, the sequence of which de-
termine the final structure. The strands containing the guanines that contribute
to the structure can be from the same molecule (intramolecular), or from many
(intermolecular). The strands can be going in the same direction (parallel con-
formation, Figure 1.1a), or one or more can go in the opposite direction (anti-
parallel conformation, Figure 1.1b). Interestingly however, RNA molecules have
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Figure 1.1: Non-canonical nucleic acid formations. a) A representation
of a unimolecular parallel G4 structure, with the circles representing guanine
nucleotides. b) A representation of a unimolecular anti-parallel G4 structure, with
the circles representing guanine nucleotides. c) A representation of a unimolecular
i-motif structure, with circles representing cytosine nucleotides (Kaushik et al.,
2016).
been known to exclusively form parallel G4s (Fay et al., 2017), the reason for this
is not yet fully elucidated.
The way in which the G4 tetrads stack, affecting parallel or anti-parallel topology,
is dependent on the glycosidic bond angles of the guanine bases involved. The
glycosidic bond connecting the 1’ carbon on the deoxyribose to the nitrogenous
base can be rotated to be in either a syn conformation, where the six member ring
of the purine is adjacent to the oxygen in the deoxyribose sugar (unfavourable),
or in an anti conformation, where the 6 member ring of the purine is positioned
away from the sugar. When the glycosidic bonds are all in the anti conformation,
this leads to parallel topology. When glycosidic bond angles alternate between
syn and anti positions, this leads to anti-parallel conformations (Masiero et al.,
2010). In addition to these variations involving G-tracts, nucleotides not par-
ticipating in G-tetrad formation also contribute to the structure. The length of
the loops outside of the G4 play a part in determining parallel or anti-parallel
conformation as well. The shorter the loops, the more thermodynamically stable
the parallel conformation becomes (Hazel et al., 2004). Loops are either lateral,
where adjacent strands are joined on either the top or bottom of the G4 (Fig-
ure 1.1b), diagonal, where opposite strands join diagonally on either the top or
bottom of the G4, or propeller, where strands are joined from opposite ends of
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the G4 (Ogloblina et al., 2015), Figure 1.1a). Together, these structural intri-
cacies provide unique qualities to each G4 molecule, allowing potential for highly
targeted ligand binding.
Since G4s were discovered in 1962 (Gellert et al., 1962), many researchers have
questioned the biological relevance of such structures, and deemed them an in
vitro artefact. Possible G4 forming DNA sequences have been found through-
out the human genome in promoters (including those of oncogenes, Siddiqui-Jain
et al. (2002)), 5’ and 3’ untranslated regions, splice sites (Huppert and Bala-
subramanian, 2005), and in their largest abundance in repetitive sequences such
as telomeres (Wang and Patel, 1993), suggesting G4s may have novel roles in
genome regulation. High-resolution sequencing-based methods have found over
700,000 DNA G4 structures in the human genome (Chambers et al., 2015). These
G4-forming sequences can be extracted, and depending on their length, assessed
by dimethyl sulfate (DMS) footprinting, in order to isolate G4 structures unable
to be degraded (Sun and Hurley, 2010), or circular dichroism (CD) spectroscopy
in order to identify G4 structure by a characteristic CD profile (Randazzo et al.,
2012). Another piece of supporting evidence is the fact that a number of hu-
man proteins including nucleases, helicases, and resolvases have been shown to
bind G4s (Brázda et al., 2014). Further to this, antibodies raised against G4
structures have been able to detect possible G4 formation in immunofluorescence
assays (Biffi et al., 2013).
As stated by Aaron Klug following the discovery of G4s, ”If G-quadruplexes
form so readily in vitro, Nature will have found a way of using them
in vivo”.
1.1.2 i-Motifs
An i-motif is a type of non-canonical nucleic acid structure whereby cytosine
nucleobases can pair with one another, forming an intercalated, anti-parallel,
tetrameric structure (Figure 1.1c). Cytosine base-pairs must be hemi-protonated
(C:C+) in order to form Hoogsteen hydrogen bonds between N3 of each pyrimi-
dine (Gehring et al., 1993). Therefore, i-motifs were commonly thought to only
be able to form under acidic conditions. However, there is evidence that they
are capable of forming at neutral pH and at room temperature, and have also
been shown to form in the nuclei of human cells by indirect immunofluorescence
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staining using an i-motif-recognising antibody (Zeraati et al., 2018).
Of great interest, is the notion that when a G4 forms from duplex DNA, the
opposite cytosine-rich strand is in a favourable position to form an i-motif at
the same time. This raises the possibility that proteins binding to each of these
non-canonical structures may work together in their genomic function.
1.2 Chromatin
Chromosomes are formed through the intricate folding of DNA complexed with
nuclear proteins, which must be organised and protected within the three dimen-
sional space of the nucleus. The way in which this occurs is though the formation
of chromatin: the nucleoprotein complex. Two copies of each core histone, H2A,
H2B, H3, and H4, together form a histone octamer, which is referred to as the
nucleosome (Luger et al., 1997). The DNA double-helix then wraps around a
nucleosome, approximately 1.65 times with 146 bp of DNA (Davey et al., 2002),
and is referred to as the chromatosome. An array of these structures are then
referred to colloquially as ”beads on a string” due to the large globular protein
and linker DNA between the nucleosome particles. The chromatosomes then fold
to form a 30 nm fibre secured by linker histone H1, which is then further organ-
ised into distinct loops and domains in interphase (Dorigo et al., 2004; Olins and
Olins, 1974).
This microscopically defined higher order structure is then partitioned into two
distinct types of chromatin: euchromatin and heterochromatin. Euchromatin is
transcriptionally active, whereas heterochromatin is more structurally compact
and transcriptionally repressed, organising the genome into functional regions for
appropriate gene expression patterns, as well as genomic integrity (Schneider and
Grosschedl, 2007).
Active and inactive chromatin is characterised by the post-translational modifi-
cations (PTMs) present on the histones in each region. Each histone has many
possible PTMs which alter the compaction and therefore gene expression in the
area in which the modification is deposited. Chromatin modification through
PTM is done through a change in the charge of the histone due to the addition of
a PTM, and/or a protein binding to the PTM to then alter chromatin structure.
Many studies have focused on the paradigm of the Histone code, the bipartite
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PTMs on lysine 9 of H3 (H3K9), and their effects on chromatin structure and
expression. H3K9 acetylation (H3K9ac) has been shown to highly correlate with
active promoters, as well as mono-methylation of H3K9 (H3K9me1). However, di-
and tri-methylation of H3K9 (H3K9me2/3) are strongly associated with silenced
genes (Bowman and Poirier, 2015).
1.2.1 Heterochromatin
Heterochromatin formation is a fundamental architectural component of eukary-
otic chromosomes, constitutively maintained around the centromeres and telom-
eres. Heterochromatin is further partitioned into two sub-types: facultative and
constitutive heterochromatin (Brown, 1966).
Facultative heterochromatin, associated with H3K27me3, is a functional, re-
versible form of heterochromatin whereby genes may be silenced in a temporal,
or cell specific manner (Jamieson et al., 2016). Constitutive heterochromatin,
associated with H3K9me3, is a state of permanent compaction throughout the
cell cycle, present at the same loci throughout cell types, and formed in repetitive
regions of the genome, including the centromeres and telomeres (Becker et al.,
2016).
The pivotal protein enriched in heterochromatin that binds the aforementioned
H3K9me3 PTM in order to form and maintain constitutive heterochromatin is
none other than Heterochromatin Protein 1α (HP1α) (Wongtawan et al., 2011).
1.2.2 Heterochromatin Protein 1α
Referred to as a hallmark of heterochromatin, the importance of HP1 has been
suggested by the conservation of sequence and function through evolutionary
time, present in almost all studied eukaryotic organisms from fission yeast, to
plants, and to animals (Wang et al., 2000). As a non-histone chromosomal pro-
tein, HP1 establishes and maintains higher order heterochromatin structure.
The HP1 family of proteins have a distinct tripartite structure. This firstly con-
sists of an N-terminal chromodomain. The chromodomain’s primary function
6
Figure 1.2: Simple model of heterochromatin formation. Nucleosomes
bearing H3K9ac are deacetylated by histone deacetylases (HDACs), and subse-
quently methylated by histone methyltransferases (HMTs) to make H3K9me3.
HP1α can then bind H3K9me3 through its chromodomain, and dimerise through
its CSD to form heterochromatin (Kwon and Workman, 2011).
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is to bind H3K9me2/3 in order to bind HP1 to histones and therefore, chro-
matin (Bannister et al., 2001). Secondly, is the C-terminal chromoshadow do-
main (CSD). The CSD is an interface for not only dimerisation between HP1
proteins (Figure 1.2), but also as a binding site allowing for recruitment of nu-
clear chromatin modifying factors which contain the PxVxL motif (Smothers and
Henikoff, 2000). Finally, connecting the chromodomain and CSD is the hinge of
HP1 (Meehan et al., 2003).
In addition to this now well characterised tripartite structure, are the N- and
C-terminal extensions (NTE and CTE), before the chromodomain begins, and
following the CSD. Little is known about potential functionality of these areas of
HP1, apart from their roles in supporting chromodomain and CSD functionality
(Canzio et al., 2014).
In mammals, three HP1 paralogs have roles in chromatin maintenance activities.
The three HP1 proteins are HP1α, HP1β, and HP1γ, encoded by the genes CBX5,
CBX1, and CBX3 respectively, each contributing to the structure of chromatin,
as well as gene expression patterns. HP1α and HP1β localise to constitutive
heterochromatin, whereas HP1γ is distributed both in heterochromatin and eu-
chromatin (Minc et al., 1999, 2000). Given the sequence similarities between the
HP1 paralogs, the molecular basis of their distinct localisation and functionality
remains generally unknown.
HP1α is the primary HP1 paralog associated with constitutive heterochromatin,
therefore is a focus when studying heterochromatin formation. The paradigm of
the Histone code is a widely accepted model which proposes that the transcrip-
tional activity of chromatin domains is in part regulated by the PTMs present on
histone tails (Jenuwein and Allis, 2001). The multivalency of HP1α binding to
H3K9me3 through its chromodomain, and its dimerisation and binding of other
proteins through its CSD has been shown to accelerate chromatin retention of
silent marks (Kilic et al., 2015). This emphasises the importance of the chromod-
omain and CSD of HP1α in its binding to both chromatin and other effectors
on the chromatin to mediate interactions and heterochromatin formation. Con-
trary to the focus on the chromodomain’s interaction with H3K9me3, this bond
is not high affinity, with a dissociation constant of 35 µM, measured by fluores-
cence anisotropy (Hiragami-Hamada et al., 2011). Due to the weak interaction
between HP1α and H3K9me3, further recruitment mechanisms or stabilising fac-
tors are required in order to maintain HP1α presence and therefore constitutive
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heterochromatin, at pericentric and telomeric regions.
In HP1α, between the chromodomain and the CSD is the hinge region. This re-
gion was long ignored, as it was considered an unstructured hinge, just linking the
two conserved domains. Finally, in 2002, a group postulated that the chromod-
omain was not solely responsible for HP1α targeting to heterochromatin, given
that H3K9me3 is present throughout the genome, but HP1α is primarily localised
to centromeres and telomeres. Upon treating cells with RNase, it was found that
HP1α localisation was lost. Therefore HP1 may be able to recognise, and be
recruited by, an RNA component (Maison et al., 2002). Muchardt et al. (2002)
were able to show that HP1α is actually an RNA-binding protein, in which the
hinge binds RNA and contributes to the localisation of HP1α. Further to this,
three particular consecutive lysine residues (K104, K105 and K106) in the hinge
domain have now been shown to be responsible for the RNA binding ability of
HP1α.
Constitutive heterochromatin is maintained around centromeres, the central re-
gion of the chromosome where sister chromatids are attached, therefore con-
densation of pericentric regions is important to maintain faithful segregation of
chromosomes during mitosis (David et al., 2003). As one would expect, HP1α
is enriched in pericentric heterochromatin. Upon investigation, it was found
that HP1α, when sumoylated on its hinge, interacts with lncRNA transcribed
from major satellite repeats within pericentric and centric heterochromatin. Re-
searchers proposed that this lncRNA was required to target HP1α specifically to
pericentric heterochromatin, and this sumoylation of the hinge domain allowed
for the chromodomain to then bind H3K9me3, forming heterochromatin (Maison
et al., 2011).
Given the finding that a repetitive lncRNA transcribed from pericentric regions is
required for heterochromatin formation through an interaction with HP1α around
centromeres, a similar mechanism may be present at the telomeres.
1.3 Telomeres
Telomeres are the protective buffering region at linear chromosome ends (Olovnikov,
1973), preventing double-stranded DNA (dsDNA) from being degraded or recog-
nised as double-strand breaks. The highly conserved telomeric DNA sequence in
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humans consists of repeats of the sequence (TTAGGG)n (Allshire et al., 1989).
This sequence is highly conserved among vertebrates, sharing a common ancestor
over 400 million years ago (Meyne et al., 1989).
Through each round of cell division, a small, approximately 50-100 bp (Harley
et al., 1990) section of DNA is lost during DNA replication due to the removal
of the RNA primer of the last Okazaki fragment on the lagging strand (Okazaki
et al., 1968), and is referred to as the end replication problem. After many
rounds of DNA replication, the telomeres become shorter, and this is thought to
be not only a marker for the age of an organism and it’s Hayflick limit (Hayflick
and Moorhead, 1961), but also contribute to old-age related diseases like cancer
(Panossian et al., 2003). Once the telomeric sequence has been greatly reduced (in
cultured human cells, after 50-70 cell divisions (Hayflick and Moorhead, 1961))
the cell will either elicit a DNA damage response (DDR) resulting in random
recombination, or will cease to divide and place itself into a senescent state to
reduce any further DNA damage (di Fagagna et al., 2003).
The function of telomeres is extremely crucial for longevity, therefore the cell
has multiple strategies to prevent their decay. The highly conserved, repetitive,
telomeric DNA sequence has a single-stranded 3’ overhang, allowing for unique
structural formations at the chromosome ends due to strand invasion. The G-rich
3’ overhang is able to bind with the C-rich strand of previously duplex telomeric
DNA to form a telomere loop (T-loop) structure. The original G-rich sequence
may then form a displacement loop (D-loop) (Figure 1.3) and be replaced by
the 3’ overhang sequence (Griffith et al., 1999). These loop structures hide the
loose telomere ends, thereby preventing them from being recognised by the cell
as double-strand breaks (Longhese, 2008).
Another protective layer in addition to loop structures on the ends of chromo-
somes is the shelterin complex, bound to telomeric DNA to prevent telomere
degradation and recognition as double-strand breaks (De Lange, 2005). Shelterin
is a multimeric complex, consisting of six subunits. Together these subunits recog-
nise and bind the TTAGGG repeat. Telomere Repeat Factor 1 and 2 (TRF1 and
TRF2) recognise and bind the telomeric repeat in duplex DNA and then recruit
Protection Of Telomeres 1 (POT1), TRF1 interacting nuclear protein 2 (TIN2),
Repressor/Activator Protein 1 (RAP1), and Tripeptidyl Peptidase 1 (TPP1).
POT1 recognises the telomeric repeat sequence in single stranded DNA, so facili-
tates T-loop formation, with the shelterin complex present at the junction (Diotti
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Figure 1.3: Telomeres form T- and D-loops at chromosome ends via a 3’ over-
hang (Griffith et al., 1999).
and Loayza, 2011).
In order to maintain the compact structure of telomeres, they are enriched in
RNA, H3K9me3, and also HP1α. Drosophila HP1 was found to play a crucial
role in telomere function, where it was found to control capping, elongation, and
silencing of telomeres (Perrini et al., 2004). HP1γ is also localised to telomeres and
binds the shelterin component TIN2 where it acts to maintain telomere-telomere
cohesion (Canudas et al., 2011).
1.3.1 Telomeric repeat-containing RNA
As telomeres are a heterochromatic domain, this implies that they would be
transcriptionally silent. However, in 2007-2008, two groups of researchers both
happened upon the discovery of transcription at mammalian telomeres (Azzalin
et al., 2007; Schoeftner and Blasco, 2008), with TElomeric Repeat-containing
RNA (TERRA) identified as the transcript. This molecule, transcribed from
sub-telomeric regions through to the telomeric tract varies in length (100 bp to
9000 bp, Azzalin et al. (2007); Feretzaki and Lingner (2017)), and little is known
about its regulation and stability in vivo.
Deng et al. (2009) proposed that TERRA was required for the structural stabil-
ity of telomeres, as well as heterochromatin formation. Shown with RNA affinity
purification, and subsequent liquid chromatography-tandem mass spectrometry
(MS) and western blotting, the TERRA sequence bound a myriad of RNA bind-
ing proteins, including TRF1 and TRF2. Interactions with shelterin components
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were confirmed in vivo with RNA immunoprecipitation (RNA-IP) assays. The
researchers also found using RNA-IP that TERRA was able to bind HP1α and
modified histone H3, which suggests a role of TERRA in regulating heterochro-
matin formation.
Due to the G-rich sequence of telomeric repeats, the transcript, TERRA, is also
G-rich, allowing for the formation of G4s. TERRA sequences of just 10 nt long
up to 96 nt have been shown in vitro to form G4s. TERRA G4s form with
three tetrads, due to the repeat containing three consecutive guanines, which
stack together, and as TERRA is an RNA molecule, exclusively form parallel G4
topology.
TERRA has been shown to interact with proteins such as TRF2 (Deng et al.,
2009), involved in telomere protection in the Shelterin complex, and also with
RNA helicase associated with AU-rich element (RHAU) (Meier et al., 2013), an
RNA helicase, which has been established as a major cellular quadruplex resolvase
(Creacy et al., 2008; Vaughn et al., 2005). This RHAU interaction with TERRA
shows that the G4 structure of the telomeric transcript is actually recognised and
acted upon by a cellular protein, showing how a G4 structure can be utilised in
the cell.
TERRA expression has been shown to be regulated by telomere length and pres-
ence of H3K9me3 (Arnoult et al., 2012). This alludes to a telomeric feedback
mechanism, whereby long telomeres repress TERRA expression, but short telom-
eres allow transcription of TERRA, which then brings about H3K9me3 PTM and
subsequently HP1α, condensation, and therefore reduced expression and compact
telomeres.
1.3.2 Telomere elongation
To avoid the DNA damage response elicited upon telomere degradation, in spe-
cial circumstances the enzyme telomerase is able to elongate the telomeric DNA
(Blackburn et al., 1989). Telomerase (also known as terminal transferase) is an
RNA dependent DNA polymerase enzyme, which has a guide RNA molecule
complementary to the repeated sequence in telomeres. This directs the enzyme
to reverse transcribe DNA from this RNA sequence to extend short telomeres
(Lingner et al., 1997). Telomerase is not present in most cells, and in humans is
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only expressed in embryonic cells, activated lymphocytes, male germ line cells,
and adult stem cell populations (Cong et al., 2002). Telomerase has been found
to be expressed in cancer cells to evade growth-inhibitory factors and apoptosis
due to short telomeres (Wright et al., 1996). Cancer cells activate the expression
of telomerase to ensure infinite proliferative ability, therefore the strict regulation
of telomerase is of the utmost importance.
An alternate way cells increase telomere length is through alternative lengthening
of telomeres (ALT) (Bryan et al., 1997), where TERRA is involved in lengthening
of telomeres. The method for ALT has not yet been fully elucidated, particularly
the elongation step, however it is widely agreed that recombination plays a large
part. With two telomeres of similar length, one may form a loop structure to
allow for unequal recombination, resulting in one short and one long telomere.
Following this, one method proposed by Cesare and Reddel (2010) is the non-
random separation of telomere sister chromatids. After recombination, all the
longer telomere sister chromatids are segregated from the shorter ones. This re-
sults in one daughter cell with greater proliferative ability due to longer telomeres,
and the other daughter cell with diminished proliferative capacity and a decreased
chance of survival, which may result in evolved cancer cell populations. Cesare
and Reddel also put forward a second possible mechanism, which may not be
mutually exclusive of the first. They proposed that after recombination, telom-
eres could be synthesised from existing telomeric DNA sequences (rather than the
RNA template used by telomerase), whether it be from adjacent chromosomes or
the same telomere via T-loop formation.
The ALT mechanism of telomere elongation is utilised in very aggressive tu-
mours, such as glioblastoma multiform, the most prevalent form of brain tumour
in adults, which typically has a very poor prognosis (Hakin-Smith et al., 2003).
High TERRA levels are a hallmark of ALT-positive cancer cells; therefore, it is
likely that this lncRNA has a role in the ALT process. It has been proposed that
TERRA facilitates the recombination process in ALT by forming RNA:DNA hy-
brids with the C-rich strand of the telomere to allow for DNA synthesis (Arora
and Azzalin, 2015). In a recent analysis of 31 cancer types and their telomere
lengths, in around 15% of cases, elongated telomeres were found along with in-
creased TERRA (Barthel et al., 2017). Other studies have shown a correlation
between α-thalassemia/mental-retardation-syndrome-X-linked (ATRX), involved
in chromatin remodelling, and TERRA levels (Flynn et al., 2015), where ATRX
13
knockdown results in loss of cell cycle dependent regulation of TERRA and there-
fore increased TERRA and recombination mediated ALT. HP1α has also been
shown to mediate the formation of PML (promyelocytic leukaemia) bodies in the
nucleus, where ALT takes place in cancer cells (Jiang et al., 2011).
Since the discovery of TERRA, evidence linking it to telomere maintenance in
cancer is substantial, therefore this lncRNA is clearly paramount to the regulation
of telomeres, particularly immortalisation in cancer cells.
1.4 HP1α-TERRA
TERRA and HP1α have been shown to interact (Deng et al., 2009), and TERRA
functions in heterochromatin formation at telomeres. The hinge region of HP1α,
shown to have RNA binding capability, may well be responsible for the interaction
between HP1α and TERRA, allowing for the targeting of HP1α to telomeres. The
ability of TERRA to form G4s may provide the specificity required in order to
target HP1α specifically to telomeres, setting it aside from the RNA recruitment
mechanism at the centromeres dependent on sumoylation.
This TERRA association with chromatin modifier HP1α has implications associ-
ated with critically short telomeres, as well as elongation of telomeres in cancer.
TERRA is transcribed from the very region that it may be responsible for con-
densing, suggesting a negative feedback mechanism (Arnoult et al., 2012), where
long telomeres produce long TERRA molecules which repress their own tran-
scription by increased heterochromatin formation. HP1α interacts with TERRA
molecules, thus providing a mechanism for this feedback loop. A longer TERRA
has more G4s, therefore more HP1α binding sites, so recruitment of more HP1α,
thus condensing the telomeric heterochromatin and repressing transcription.
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1.5 Objectives
HP1α, a pivotal chromatin regulator, and TERRA, a telomeric transcript in-
volved in many tumourigenic processes, have been shown to interact. Given the
importance of heterochromatin formation and therefore localisation of HP1α to
telomeres, a function and mechanism for the interactions between HP1α and
TERRA needs to be explored.
A model where TERRA and HP1α interact to form and maintain telomeres
through protein recognition of a specific G4 is pivotal to understanding telomere
regulation, and also to genome organisation as a whole, showing the relevance of
non-canonical nucleic structures in epigenetic regulation.
This work seeks to understand how HP1α recognises and interacts with G4s,
specifically TERRA, necessary for the targeting of HP1α to a region of constitu-
tive heterochromatin.
Hypothesis: HP1α binding to TERRA is structure dependant, whereby HP1α
recognises the G4 structure formed by TERRA and binds via the unstructured
hinge domain.
The aims of this investigation are as follows:
- does HP1α bind TERRA?
- whether the lysine-rich hinge domain is involved in this interaction,
- if HP1α binds endogenous non-canonical nucleic acid structures,






The buffer used in experiments throughout was 1x 100 mM KCl, 50 mM NaCl,
and 20 mM NaH2PO4, at pH 8, and will be referred to as Interaction Buffer (IB).
This buffer was also prepared at pH 7, and will be referred to as IB7.
A stock of 10x IB or IB7 was prepared (1 M KCl, 500 mM NaCl, 200 mM
NaH2PO4) and filter sterilised using a 0.2 µm filter. To prepare 1x solution, 10x
stock was diluted with milli-Q H2O 10-fold.
2.2 Oligonucleotides
A 96 bp telomeric repeat-containing RNA (TERRA) 96 suspended in 100 mM
NaCl and 10 mM NaH2PO4 was a gift from Carlos Gonzalez (Instituto de Qumica
Fsica Rocasolano, Madrid, Spain), and purified according to McKenna et al.
(2007). All other oligonucleotides were obtained from Integrated DNA Technolo-
gies, purified by standard desalting by the manufacturer. Sequences are listed in
Table 2.1.
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Table 2.1: Sequence and length of oligonucleotides
Name Sequence Length (nt)
TERRA 45 (RNA) rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA rGr-
GrG rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG
45
TERRA 96 (RNA) rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA rGr-
GrG rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG
rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG rU-
rUrA rGrGrG rUrUrA rGrGrG rUrUrA rGrGrG rUrUrA
96
d-TERRA 45 GGG TTA GGG TTA GGG TTA GGG TTA GGG TTA GGG TTA
GGG TTA GGG
45
Thy45 TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT
TTT TTT
45
Oligo A TGG GTG GGT GGG TGG GTG GGT GGG TGG GTG GGT 33
Oligo B TGG GTT GGG TTG GGT TGG GTT GGG TTG GGT TGG GTT
GGG T
40
Oligo C TGG GTT AGG GTG GGT TAG GGT 21
Oligo D TGG GTG GGT TAG GGT GGG T 19
Oligo E TGG GTG GGT TAG GGT TAG GGT 21
Oligo F TGG GTT AGG GTT AGG GTG GGT 21
Oligo G TGG GTT AGG GTT AGG GTT AGG GT 23
Oligo H TGG GTT AGG GTG GGT GGG T 19
Oligo I TGG GTG GGT GGG TTA GGG T 19
Oligo 2C TGG GTT AGG GTG GGT TAG GGT GGG TTA GGG TGG GTT
AGG GT
41
Oligo 2D TGG GTG GGT TAG GGT GGG TGG GTG GGT TAG GGT GGG T 37
Oligo 2E TGG GTG GGT TAG GGT TAG GGT GGG TGG GTT AGG GTT
AGG GT
41
Oligo 2F TGG GTT AGG GTT AGG GTG GGT GGG TTA GGG TTA GGG
TGG GT
41
Oligo 2G TGG GTT AGG GTT AGG GTT AGG GTG GGT TAG GGT TAG
GGT TAG GGT
45
bcl2 AGG GGC GGG CGC GGG AGG AAG GGG GCG GGA GCG GGG
CTG
39
cmyc 2 GGG TGG GTA GGG TGG G 16
ckit2 GGG CGG GCG CCA GGG AGG GG 20
KRAS32 2 AGG GCG GTG TGG GAA GAG GGA AGA GGG GGA GG 32
SRC2 GGG GCA GCT GGG TCG CTC GGG GAA CGG GG 29
SRC3 GGG AGG GAG GGC TGG GGG 18
SRC14 GGG TGG GCT GAC GGG GCA GAA TGG GAG GG 29
SRC16 GGG CTG CTG GGA CTG GTT GGG AGG GCA CTC TGG GG 35
SRC19 GGG TCC CCT GGG CCT GGG CGG GAG CGG GGA GGG G 34
Carlos LL3rep TCG TTC CGT TTT TCG TTC CGT TTT TCG TTC CGT TTT TCG
TTC CGT
45
DAP i-motif CCC CCG CCC CCG CCC CCG CCC CCG CCC CC 29
HIF-1alfa i-motif CGC GCT CCC GCC CCC TCT CCC CTC CCC GCG C 31
PDGF-A CCG CGC CCC TCC CCC GCC CCC GCC CCC GCC CCC CCC CCC
CC
41
JAZF1 i-motif CCC CCC CCG CCC CCG CCC CCG CCC TCC CCC C 31
BCL-2 i-motif CAG CCC CGC TCC CGC CCC CTT CCT CCC GCG CCC GCC CCT 39
C-telomere 45 CCC TAA CCC TAA CCC TAA CCC TAA CCC TAA CCC TAA CCC
TAA CCC
45
Oligonucleotides (apart from TERRA 96) were folded in 1x IB or IB7 (for the
formation of i-motifs and dsDNA) by heating at 90 ◦C for 5 minutes, then cooled
gradually to room temperature.
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2.3 Biolayer Interferometry
Biolayer Interferometry (BLI) was performed on the BLItz system (ForteBio),
using Ni-NTA biosensor tips. Tips were hydrated for at least 10 minutes prior to
each experiment in 250 µL of IB (or IB7 if i-motifs or dsDNA were being tested).
The Advanced Kinetics mode of the BLItz Pro 1.2 software was used to monitor
the binding of each species at the various steps. Shaking of the tip was set to
2200 rpm (default for kinetics experiments).
The initial baseline step (60 s) was performed in 250 µL of 1xIB within a black
opaque 0.5 mL Eppendorf tube, then 4 µL of his-tagged protein (in a drop holder)
was incubated with the Ni-NTA tip for 5 minutes. His- Heterochromatin Pro-
tein 1α (HP1α) was used at 100 µg/mL, other paralogs of his-tagged HP1 were
matched relative to this level of binding (3.5 nm, HP1β at 80 µg/mL, HP1γ at
70 µg/mL, and HP1α-3KA at 140 µg/mL). The tip was then washed in 250 µL
of 1xIB (60 s, in a black opaque 0.5 mL Eppendorf tube), to remove any protein
not bound to the tip with high affinity. The tip was then incubated with 4 µL of
500 nM folded oligonucleotide (for 5 minutes in drop holder) for a typical bind-
ing experiment. For titrations, the concentration of oligonucleotide was varied.
Finally, dissociation was measured by washing in 250 µL of 1xIB in a black 0.5
mL Eppendorf tube for 5 minutes.
Reference experiments, where 1xIB was added in the place of oligonucleotide,
were also performed. The reference for each protein was then subtracted from
subsequent experiments in order to isolate the specific response from adding lig-
and, accounting for dissociation of protein from the tip. No oligonucleotide was
shown to bind the Ni-NTA biosensor tip in the absence of his-tagged protein
(data not shown).
BLItz Pro 1.2 software was used for curve fitting and KD calculations. As arte-
facts can be produced when starting and stopping each experiment to change
between drop holder and Eppendorf tube, the data was processed to begin each
step where the previous one had left off. For example, the dissociation data was
set to begin at exactly the amount of binding at the end of the association step.
When titrations were performed to elucidate KD, a global curve fit was used to
take all binding curves and their concentrations into account.
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2.4 Protein sequence alignment
Alignment was performed using the CLUSTAL Omega Multiple Sequence Align-
ment tool, version 1.2.4, with default parameters (Sievers et al., 2011).
2.5 Circular Dichroism
Circular Dichroism (CD) spectroscopy was performed on the Chirascan (Applied
Photophysics Ltd) instrument using 5-10 µM RNA or DNA (in order to produce
maxima above 10 CD mdeg), diluted in 1xIB. Measurements were performed on
250 µL of oligonucleotide inside of a quartz 1 mm cuvette.
Scans were gathered from 200 nm to 350 nm with 1 nm data pitch, on continuous
scanning mode, with a response of 0.25 seconds and bandwidth 1 nm. 1xIB was
scanned prior to each experiment, and subtracted from each scan. Three scans
were made for each oligonucleotide, averaged, and then smoothed by averaging
10 neighbour points. Chirascan v.4.4.1 was used for operation of the Chirascan
instrument, as well as data processing described.
2.6 Polyacrylamide Gel Electrophoresis
2.6.1 SDS-PAGE
For sodium dodecyl sulfate (SDS) Polyacrylamide Gel Electrophoresis (PAGE),
a 12% acrylamide/bisacrylamide resolving gel was made containing 375 mM Tris
HCl pH 8.8, 0.1% SDS, 0.1% ammonium persulfate (APS), and 0.1% tetram-
ethylethylenediamine (TEMED). A stacking gel of 5% acrylamide/bisacrylamide,
125 mM Tris HCl pH 6.8, 0.1% SDS, 0.1% APS, and 0.1% TEMED was also made
and set atop the resolving gel.
6x loading buffer (62.5 mM Tris pH 6.8, 1.67% SDS, 7.5% glycerol, 0.01% bro-
mophenol blue, 35.75 mM 2-Mercaptoethanol) was added to a final concentration
of 1x to each sample, then heated to 99 ◦C for 5 minutes prior to loading. Elec-
trophoresis was performed with 12% resolving gel below 5% stacking gel in 1x
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TGS buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3) at a constant 35
mAmp until the dye front reached the bottom of the gel.
Unless otherwise specified, the gel was stained with 0.1% Coomassie in 30%
methanol and 10% acetic acid, washed with H2O, and de-stained with 20%
methanol and 10% acetic acid until sufficient de-staining had occurred. The
gel was then imaged on a Gel-Doc instrument.
2.6.2 Native PAGE of Oligonucleotides
A 20% acrylamide/bisacrylamide native polyacrylamide gel was made containing
1x TBE buffer (45 mM Tris-borate, 1 mM EDTA) with addition of salts con-
tained in the IB (100 mM KCl, 50 mM NaCl, 20 mM NaH2PO4), referred to as
TBE+salts, 0.1% APS, 0.1% TEMED, and H2O.
To 15 µL of 10 µM oligonucleotide, 3 µL of 0.0025% bromophenol blue in 10%
glycerol and 1x IB was added, and then the total 18 µL of each mixture was
loaded. The gel was electrophoresed at 4 ◦C in 0.5x TBE+salts at 5 Watts per
gel until the dye front had travelled the majority of the way down the gel. To
combat overheating and acidity of the buffer during the electrophoresis, the buffer
was removed from the apparatus, mixed, and added back every hour. The gel
was rinsed in H2O, and then stained in 0.35% Stains-All in 50% formamide for 15
minutes in the dark. The gel was then washed in H2O three times and de-stained
in H2O, no longer in the dark, until sufficient de-staining had occurred. The gel
was then imaged on the Gel-Doc under white light.
2.6.3 Native PAGE of Proteins and Complexes
A native polyacrylamide gel was made the as the oligonucleotide native PAGE
(Section 2.6.2), but with only 5% acrylamide/bisacrylamide for protein separa-
tion.
To 10 µL of 0.5 µg/µL protein (5 µg), 0.0025% bromophenol blue in 10% glycerol
and 1x IB was added, and then loaded. The gel was performed as previously
described in Section 2.6.2. The gel was rinsed in H2O, fixed in fixation solution
(40% ethanol, 10% acetic acid), washed again in H2O, and stained with QC
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Colloidal Coomassie Stain (Bio-Rad) overnight (approximately 18 hours). De-
staining was then performed by soaking the gel in H2O, and then imaged on the
Gel-Doc.
2.7 Protein Cross-linking
Proteins were prepared at a range of concentrations, to a volume of 20 µL.
Formaldehyde was added to a final concentration of 1%, and incubated with
protein for 5 minutes at 37 ◦C. A non-cross-linked control was performed by
adding 1xIB instead of formaldehyde, but otherwise treated the same as all other
samples. The cross-linking properties of formaldehyde were then quenched by
addition of tris HCl pH 8 to a final concentration of 100 mM. 6x loading buffer
(62.5 mM tris pH 6.8, 1.67% SDS, 7.5% glycerol, 0.01% bromophenol blue, 35.75
mM 2-mercaptoethanol) was then added (to a final concentration of 1x) to de-
nature protein and to aid in loading. Because high temperatures can reverse
cross-links, denaturing with loading buffer was performed at 65 ◦C rather than
99 ◦C, because this has been shown to sufficiently denature protein while min-
imising cross-link reversal (Klockenbusch and Kast, 2010). Samples were then
loaded and separated by SDS-PAGE (Section 2.6.1). The gel was then stained
with QC Colloidal Coomassie Stain as described previously, and imaged using
the Gel Doc.
2.7.1 Protein Size Estimation
To estimate the sizes of cross-linked products, the protein standard marker was
first measured from the beginning of the resolving gel to each band. The retention
factor (Rf) for each of these measurements was then calculated by dividing by the
distance from the beginning of the resolving gel to the dye front. The log of the
molecular weight of each of the bands was calculated and subsequently plotted
against the Rf of each of the bands to produce a standard curve.
The gel this analysis was performed on had a marker on each side of the gel,
therefore each of these was measured and plotted as above. Although similar, the
right-hand-side marker was chosen to proceed with estimating molecular weights,
due to the higher R-value of the linear trendline plotted. The 250 kDa, 150 kDa,
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and 100 kDa bands did not fit the linear relationship, so were excluded from
trendline equation calculations. However, this means that weights could only be
measured up to 75 kDa accurately.
Further to this, the gel appeared to have warped during the electrophoresis pro-
cess, where proteins in the centre of the gel were less mobile than those at the
left and right edges, which affected protein size estimation.
HP1α protein bands were measured, divided by the dye front length to give Rf
values for each band. Using the equation given by the linear trendline, x(Rf) was
used to solve for y(log MW), and the inverse log of this value was calculated to
give the molecular weight estimate of the protein.
2.8 Isothermal Titration Calorimetry
Prior to performing isothermal titration calorimetry (ITC), dialysis of protein or
nucleic acid was performed to ensure accurate buffer matching, reducing the heat
of dilution. 50 µL of HP1α or 50 µL of TERRA 45 was dialysed in a 50 µL
dialysis button (Hampton Research) with a 500-1000 Da MWCO membrane cut
to size secured with an O-ring. Dialysis was performed in 100 mL of buffer at 4
◦C with stirring over 48 hours, with one buffer change after 24 hours.
The MicroCal iTC200 isothermal titration calorimeter instrument was used, along
with its associated software.
Water was held in the reference cell, and the cell temperature was set to 25 ◦C.
The reference power was 3 µcal/second, with an initial delay of 60 seconds, and
a stirring speed of 750 rpm. There was an initial injection of 0.5 µL for each ex-
periment, and spacing between injections was 120 seconds with a 5 second filter
period. RNA was held in the syringe, injected into the sample cell containing pro-
tein. Concentrations of protein and RNA, and number and volume of injections
are discussed in Section 4.3.
Prior to each experiment, the heat of dilution was measured by an identical
experiment with buffer in the sample cell in place of protein (reference).
Analysis was performed using MicroCal Analysis software, under the ITC200 set-
ting. Firstly, reference experiments were subtracted from their respective ITC
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experiments. Anomalous data was removed, including the first 0.5 µL injection
in all cases. A one-to-one curve was then fit after three iterations to give output
data.
2.9 Small-Angle X-ray Scattering
Small-angle X-ray scattering (SAXS) data were measured at the Australian Syn-
chrotron on the SAXS/WAXS beamline using a sheath flow environment. A
wavelength of 1.0332 Å (12 keV radiation) and detector distance of 1575 mm was
implemented.
Sample was degassed, and then 50 µL was injected and eluted at 0.2 mL/min.
Data was collected using a co-flow setup to mitigate radiation damage, with size
exclusion chromatography coupled with SAXS (SEC-SAXS), using an Agilent
AdvanceBio SEC, 2.7 µm, 300 Å, 7.8 300 mm, eluting with 1xIB with 5%
glycerol.
Data was processed using CHROMIXS (Panjkovich and Svergun, 2017) to man-
ually select the appropriate SEC peak, and subtract eluted buffer. Analysis was
then performed using PRIMUS (Konarev et al., 2003), as part of the ATSAS data
analysis package.
2.10 Protein Expression and Purification
Mus musculus HP1α, HP1α-3KA, HP1β, and HP1γ cDNA (human HP1α pro-
tein sequence has 98% similarity to mouse, HP1β and HP1γ have 100% protein
sequence identity to mouse) were cloned into pPROEX HTb with BamHI and




Cloning of the protein amino acid sequences was done previously for this project,
using standard cloning techniques. This plasmid was chosen to add a hexahisti-
dine tag to the protein, to aid in purification and also for use with the Ni-NTA
biosensors.
This plasmid contains an ampicillin resistance gene for selection purposes, and
also the lac promoter to control induction with the addition of IPTG (Figure
A.1).
2.10.1.2 Host
The strain used for expression was Rosetta 2(DE3) competent cells, which are
a derivative of the BL21 strain of Escherichia coli. These cells are made to
enhance the expression of eukaryotic proteins by containing codons rarely used
in E. coli, by supplying tRNAs for 7 extra codons (AGA, AGG, AUA, CUA,
GGA, CCC, and CGG). The tRNAs are present on a plasmid that also carries
a chloramphenicol resistance gene, aiding in selection. Previous work was done
that showed Rosetta 2 cells were best for expression of HP1 protein from the
pPROEX HTb vector (done by Andy Hollings).
2.10.1.3 Growth
Firstly, an aliquot of Rosetta 2 cells were thawed on ice, 1 µL of 100 ng/µL of
vector was added, and the mixture was incubated on ice for 30 minutes, at 42 ◦C
for 45 seconds, and again on ice for 2 minutes. 500 µL of Super Optimal Broth
was then added, and this was then incubated at 37 ◦C for 1 hour.
50 µL of this was then spread onto an LB agar plate with 34 µg/mL chlorampheni-
col for the Rosetta 2 plasmid containing tRNAs, and also 100 µg/mL ampicillin
to select for cells that contain the pPROEX HTb plasmid and therefore had
ampicillin resistance.
The agar plate was then incubated overnight at 37 ◦C. Following this, a single
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transformed colony was transferred to 10 mL of LB containing 34 µg/mL chlo-
ramphenicol and 100 µg/mL carbenicillin in a 50 mL falcon tube. Carbenicillin
was used instead of ampicillin because it is more resistant to the beta-lactamase
enzymes present in E. coli that degrade these types of antibiotics, and therefore
won’t be degraded over long time periods such as overnight incubations. This
10 mL culture was then incubated again overnight at 37 ◦C, with shaking at 200
rpm. The following day, the tube was centrifuged at 3000 xg for 5 minutes. The
supernatant was discarded, and the pellet resuspended in 10 mL of fresh LB.
2.10.1.4 Induction
10 mL of the resuspended pellet was used to innoculate each 1 L of media (LB +
100 µg/mL carbenicillin and 34 µg/mL chloramphenicol) in a 5 L flask. This 1
L of media and inoculant was incubated at 30 ◦C, shaking at 180 rpm, until the
OD600 had reached 0.4. The culture was then chilled for 15 minutes on ice before
being induced by addition of 0.4 mM IPTG, and then incubated overnight at 22
◦C, shaking at 180 rpm.
2.10.1.5 Harvest
Overnight induced cultures were centrifuged at 3000 xg for 10 minutes at 4 ◦C,
supernatant was removed, and cells were resuspended in wash buffer (10 mM Tris
HCl pH 8, 100 mM NaCl). This was then centrifuged at 3000 xg for 10 minutes at
4 ◦C. Supernatant was again removed, and cells were resuspended in lysis buffer




Cells suspended in lysis buffer firstly went through two freeze-thaw cycles at -80
◦C. 100 µg/mL DNase was then added before subjecting this solution to 4000 psi
using a hydraulic press, twice.
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Lysate was then centrifuged at 3000 xg for 10 minutes, and the supernatant
removed and filtered through a 0.2 µm filter.
2.10.2.2 Affinity Chromatography
Affinity chromatography was performed with 10 mL of Ni-NTA resin in a column
attached to the ÅKTA Prime Plus (GE Healthcare).
Imidazole was added to the lysate to a final concentration of 20 mM. Lysate was
loaded onto the column at a flow rate of 1 mL/min, and washed firstly with lysis
buffer (20 mM sodium phosphate, 300 mM NaCl, 20 mM imidazole, pH 7.4),
and then washed with wash buffer (20 mM sodium phosphate, 300 mM NaCl, 50
mM imidazole, pH 7.4). Elution was then performed with elution buffer (20 mM
sodium phosphate, 300 mM NaCl, 300 mM imidazole, pH 7.4)
2.10.2.3 Size Exclusion Chromatography
Size Exclusion Chromatography (SEC) was performed with a Superdex 200 10/300
GL column attached to the ÅKTA Explorer. Eluate from affinity chromatography
was concentrated and desalted using Vivaspin 20 (5 kDa MWCO) ultrafiltration
devices (GE Healthcare, UK).
250 µL of eluate was loaded into a 500 µL sample loop, and and injected onto
the column at 0.3 mL/min with 1xIB. Fractions were then concentrated using
Vivaspin 20 (5 kDa MWCO) ultrafiltration devices.
An SDS-PAGE of SEC fractions showing purity of HP1α is shown in Figure A.2.




Characterising the specificity of
the HP1α-TERRA interaction
To mimic the in vivo structure of transcribed telomeric repeat-containing RNA
(TERRA) molecules, sequences should contain a bare minimum of eight telomeric
repeats, with longer molecules being more representative of the true structural
arrangement (Collie et al., 2010). Therefore, to recapitulate the structure of
the G-quadruplexes formed by longer in vivo TERRA molecules in terms of in-
tramolecular interactions between multiple G-quadruplexes, a TERRA molecule,
termed TERRA 96 due to its 16 repeats of the 6 nt (UUAGGG)n sequence,
was transcribed, purified, and kindly gifted for this purpose by Carlos Gonzales
(Instituto de Qumica Fsica Rocasolano, Madrid, Spain).
Biolayer Interferometry (BLI) was performed to measure the association of Hete-
rochromatin Protein 1α (HP1α) with RNA and DNA molecules. This technique
measures the differences in incident white light through two surfaces within a
biosensor tip. One surface is designed to immobilise molecules, as it is coated
with a bio-compatible matrix chosen for the molecule of choice. The other sur-
face is used as a reference (Figure 3.1a). The difference measured between the
sample and reference light is measured in nm and used as a measure of binding
(Figure 3.1b).
To measure the greatest amount of binding, it is best if the smaller molecule is
immobilised on the tip, in order to detect the addition of the larger molecule that
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Figure 3.1: BLI technology, a) showing a representation on the inside of a tip in
absence and in presence of sample molecules (orange), which increases the length
that the light travels through, b) shift of the interferometric profile due to binding
of sample, and therefore a change in the wavelength of light (Janzon, 2013).
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it may interact with. This was originally attempted with biotinylated oligonu-
cleotides immobilised on a streptavidin tip, which was then immersed in HP1α.
However, it was found that HP1α was also able to bind to the biosensor tips.
Therefore, it was decided to immobilise his-tagged HP1α onto Ni-NTA tips and
measure the association of unlabelled oligonucleotides.
Circular Dichroism (CD) spectroscopy was used to assess the particular structures
formed by the RNA and DNA molecules used in this study. This technique
measures the difference in absorption of circularly polarised light by a molecule
containing a chiral chromophore. The circularly polarised light can be rotated
left or right at any given wavelength. The degree which circularly polarised light
has been rotated to the right is subtracted from that which has been rotated to
the left at each wavelength, and therefore certain structures have characteristic
minima and maxima over a spectrum that pertain to its conformation.
In the case of G4s, guanine is a chromophore, that is linked to a chiral deoxyribose.
The homopolar stacking of G-tetrads, which is evident in G4-DNAs and G4-
RNAs of parallel topology with syn glycosidic bonds, causes positive CD signal
at around 260 nm, and negative CD signal at around 240 nm. Any heteropolar
stacking of G-tetrads caused by an anti-parallel topology causes a positive CD
signal around 290 nm, and a negative CD signal around 260 nm. This allows for
the characterisation of G4s that are either in a parallel conformation, where all
strands are in the same orientation, or of an anti-parallel topology.
This chapter will explore, using the techniques explained above, the binding of
HP1 protein to non-canonical nucleic acid structures by BLI, and conclusions will
be drawn about the specificity of those interactions determined by the structure
of each nucleic acid using CD spectroscopy.
3.1 HP1α binds TERRA through its lysine-rich
hinge
Given that the HP1 proteins were purified using a hexahistidine tag, they are
compatible with the Ni-NTA (NTA) biosensors available. As described in Sec-
tion 2.3, his-tagged HP1α was immobilised on a Ni-NTA biosensor, and the tip
was then immersed in 500 nM TERRA 96, and subsequently washed in 1xIB.
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Figure 3.2: Binding of HP1 paralogs with TERRA 96. BLI performed
with each HP1 paralog or mutant immobilised on a biosensor, with addition of
TERRA 96, and subsequent washing in 1x IB to show the respective association
and dissociation of TERRA 96 to the protein.
BLI showed a high response between HP1α and TERRA 96, indicating association
of the RNA with the immobilised protein. (Figure 3.2). This confirmed the
results shown by Deng et al. (2009), where HP1α binds to endogenous TERRA
(using RNA ChIP and RNA IP). The RNA IP experiment also showed binding of
HP1β with endogenous TERRA, therefore BLI was performed with all paralogs
of his-tagged HP1 immobilised on the tip. TERRA bound neither of the other
two paralogs of HP1 substantially. However, TERRA 96 bound to HP1γ with a
slightly higher response than TERRA 96 binding to HP1β.
The hinge domain of HP1α is an RNA binding region. An RNA binding mutant,
HP1α-3KA, with three lysine residues substituted for alanine (residues 104-106)
in the hinge domain (Figure 3.3), has been demonstrated to lack RNA binding
capability (Muchardt et al., 2002). Therefore, HP1α-3KA was immobilised on a
biosensor tip, and tested for its interaction with TERRA 96.
BLI with HP1α-3KA immobilised, immersed in TERRA 96 showed a small amount
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Figure 3.3: HP1 paralog hinge alignment. Alignment of the hinge region
(between the chromodomain and chromoshadow domain of each paralog) using
CLUSTAL O(1.2.4) multiple sequence alignment (Sievers et al., 2011). The num-
bers above the sequence indicate the amino acid position of the first and last hinge
residue in the HP1α amino acid sequence. The black line indicates the three ly-
sine residues in HP1α that were exchanged for alanine residues in the HP1α-3KA
mutant. An ”*” (asterisk) indicates positions which have a single, fully conserved
residue. A ”:” (colon) symbol indicates conservation between groups of residues
with strongly similar properties. A ”.” (period) indicates conservation between
groups of weakly similar residues.
of binding. This however was significantly less binding than when WT HP1α was
immobilised on the tip and immersed in TERRA 96 (Figure 3.2). The abro-
gated binding by TERRA 96 to HP1α-3KA suggests the lysine patch in the hinge
domain is essential for this interaction.
Due to the limited supply of TERRA 96, further analysis was carried out with a
smaller, commercially synthesised RNA molecule. Termed, TERRA 45, this 45
nt RNA (G3(UUAGGG)7) has half the number of G-tracts of TERRA 96 (Table
2.1).
The same experiment as in Figure 3.2 was performed with TERRA 45, where
each paralog, as well as the HP1α-3KA mutant was immobilised and tested for
binding by immersion in TERRA 45 using BLI (Figure 3.4). This, as expected,
yielded similar results to the TERRA 96 binding to HP1 paralogs and mutant
(Figure 3.2), with high binding response of TERRA 45 to HP1α, abrogated
binding to HP1α-3KA, and low binding to HP1β and HP1γ.
3.2 Structure-dependent binding of HP1α
The sequences of TERRA used in BLI experiments contain G-tracts that would be
expected to form G4s. For TERRA 96, this is known, as CD had been done prior
by whom it was produced (Garavis et al., 2013). CD spectroscopy of TERRA
96 showed that it indeed formed a G4 structure. Due to characteristic positive
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Figure 3.4: Binding of HP1 paralogs with TERRA 45. BLI performed
with each HP1 paralog or mutant immobilised on a biosensor, with addition of
TERRA 45, and subsequent washing in 1x IB to show the respective association
and dissociation of TERRA 45 with each protein.
ellipticities at 210 nm and 265 nm and a peak with negative ellipticity at 240 nm
(group I according to classification proposed by Karsisiotis et al. (2011)) this is
consistent with parallel G4 topology. CD spectroscopy was also performed on the
commercially produced TERRA 45, which showed virtually identical ellipticities
(Figure 3.5), showing that TERRA 45 also forms parallel G4 topology with
homopolar stacking of G-tetrads.
Since TERRA is a G-rich transcript that can form G4s, the coding strand from
the telomeres of which it is produced from is also G-rich. Therefore, a 45 nt DNA
molecule with the same sequence as TERRA 45, only with deoxyribose instead
of ribose, and thymine instead of uracil, was produced commercially and termed
d-TERRA 45 (Table 2.1).
Due to its G-rich sequence, d-TERRA 45 would be expected to form G4s, there-
fore CD spectroscopy was performed to test this. The CD spectrum showed that
d-TERRA 45 indeed formed a G4 structure (Figure 3.6). However, due to max-
ima at 265 nm and 295 nm, the structure is deemed as ”hybrid”, with a higher
maximum at 295 nm corresponding to heteropolar stacking between guanines,
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Figure 3.5: CD spectrum of TERRA 45. Spectrum of a 5 µM sample of
TERRA 45 shows a maximum at approximately 265 nm, and a minimum at 240
nm, indicating a parallel G4 topology.
which is realised in anti-parallel G4s. As per the classification by Karsisiotis
et al. (2011), it is a group II anti-parallel G4, with just one propeller (parallel-
type) loop.
As a control for general DNA binding, a 45 nt string of thymidines, Thy45,
was also produced. CD spectroscopy of Thy45 showed a spectrum of a typical
(Vorlickova et al., 2012) unstructured ssDNA (Figure 3.6).
Binding between HP1 proteins and d-TERRA 45 was then tested by BLI as
previously described. Addition of d-TERRA 45 to immobilised HP1 paralogs or
mutant showed effectively no binding (Figure 3.7). No significant interaction
was detected between HP1α and Thy45.
In vivo, d-TERRA 45, effectively the G-rich strand of telomeric DNA, may not
be in its G4 form, but in a typical double-helix structure with the C-rich strand
of the telomere. Therefore, d-TERRA 45 was annealed to its C-rich counterpart
(C-telomere 45, Table 2.1) to form a 45 bp duplex to model the telomeric DNA.
Firstly, to confirm that the DNA had annealed in a double-helix structure, CD
spectroscopy was performed. This showed typical features of a dsDNA (Vorlickova
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Figure 3.6: CD spectra of d-TERRA 45 and Thy45. Spectra of a 5 µM
sample of d-TERRA 45, and a 5 µM sample of Thy45.
Figure 3.7: BLI spectroscopy of d-TERRA 45 and Thy45. Assessing the
binding between each HP1 paralog or mutant, bound to the tip, with addition of
d-TERRA 45, or with HP1α immobilised on the tip with addition of Thy45.
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et al., 2012), confirming duplex formation (Figure 3.8a).
BLI was then performed to test whether HP1α would bind this 45 bp telomeric re-
peat duplex. With HP1α immobilised and then immersed in annealed d-TERRA
45 and C-telomere 45, BLI showed no significant binding (Figure 3.8b).
TERRA 45 is an RNA G4 with parallel topology which binds HP1α, and d-
TERRA 45 is a DNA G4 with anti-parallel topology that does not bind HP1α.
To test whether HP1α binding ability is simply a preference for RNA over DNA,
as HP1α did not bind the other DNA molecules tested, an RNA control sample
was also tested.
Given that TERRA 45 and TERRA 96 are highly ordered RNA molecules, HP1α
was tested for its binding with the highly ordered RNA molecule, tRNA. Firstly,
to confirm that the RNA was indeed folded into the typical tRNA structure,
CD was performed, affirming that it had the same ellipticities (Figure 3.9a) as
published CD spectra of tRNA (Blum, C. Uhlenbeck, & Tinoco, 1972). By BLI,
with HP1α immobilised on the tip, and immersed in tRNA, it was shown that
tRNA did not bind to HP1α (Figure 3.9b).
To test whether this dramatic shift in binding between TERRA 45 and d-TERRA
45 was due to the conformational differences in G4 formation, several DNA
oligonucleotides derived from the 45-mer telomeric repeat in which the length
of loop regions varied were investigated (Table 2.1). It is generally accepted
that shortening of loops from three to one nucleotide can force G4s to adopt a
parallel rather than anti-parallel topology (Mateus WebbadaSilva 2009, Hazel,
2004), therefore the loops between G-tracts of d-TERRA 45 were altered and
then their conformations tested by CD spectroscopy.
The d-TERRA 45 sequence was altered to shorten the loops (ATTGGG), remov-
ing either A (TTGGG) (Oligo B) or AT (TGGG) (Oligo A), to attempt to force
the DNA into a parallel topology. Shorter variations of d-TERRA 45 were chosen
with various loops shortened to just T, or remaining as ATT in different positions
to find exactly which loops contributed to parallel topology (Table 2.1).
Both Oligo A and Oligo B exhibited CD spectra of G4s in the parallel topology
(Figure 3.10) due to the shortening of the loop of the G-quadruplex. Oligos D,
H, and I also formed parallel G-quadruplexes, whereas Oligos E and G formed
anti-parallel conformations. Oligos D, H, and I all have sequences with just
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Figure 3.8: CD and BLI of telomere duplex 45. a) CD spectrum of a 45
bp duplex of the telomeric repeat. b) BLI measurements assessing the binding of
45 bp duplex telomeric DNA to HP1α bound to the tip.
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Figure 3.9: CD and BLI of tRNA. a) CD spectrum of a 5 µM sample of
tRNA. b) BLI measurements assessing the binding of tRNA to HP1α bound to
the tip.
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one TTA loop, showing that just two of the three loops must be shortened for
parallel G-quadruplex formation. Oligos E and G both had at least two TTA
repeats sequentially from the 3’ end of the oligonucleotide, which prevented them
from forming parallel topologies. CD spectra of Oligos C and F showed a positive
peak at 260 nm, as well as a positive peak at 295 nm, though at a lower intensity
(Figure 3.10), which suggests presence of G-tetrads with heteropolar stacking
of guanines.
BLI was then performed with immobilised HP1α on the tip, and immersion in
each aforementioned oligonucleotide to test for binding.
Given the differences in length between Oligo A and Oligo B compared with Oligos
C-I, and the dependency on a molecule’s size to interfere with light in BLI, these
oligonucleotides were found to be not comparable. None of the shorter Oligos (C-
I) produced a high BLI signal (Figure A.4), indicating that either there was no
binding between HP1α and these oligonucleotides, or that these oligonucleotides
are too small to produce a significant signal upon binding.
Selected oligonucleotides were elongated, with their original sequence repeated
twice in order to provide DNA of sufficient molecular weight for BLI analysis.
Oligo C and Oligo D were chosen to add parallel G4s to the dataset, and Oligo
E, Oligo F, and Oligo G were chosen to add anti-parallel G4s. CD was then
performed on the elongated oligonucleotides (denoted by addition of a ”2” to
the name of the oligonucleotide (Figure 3.10)). Oligo 2C and Oligo 2D formed
parallel G4 conformations as expected. Oligo 2G also formed the expected anti-
parallel conformation. However, Oligo 2E and Oligo 2F both formed parallel G4s.
This could be due to each of them possessing two short loops containing just one
thymidine in the middle of their sequences, where Oligo 2G only has one short
loop.
With HP1α immobilised on the tip, it was then immersed in each of the elongated
oligonucleotides, along with Oligo A and Oligo B, and tested for their binding with
HP1α using BLI. All of these oligonucleotides, bar Oligo 2G, showed binding with
HP1α, while the only anti-parallel oligonucleotide did not show any significant
binding (Figure 3.12). Of note, the response to Oligo B binding to HP1α
exceeded that of TERRA 45 (Figure 3.4) at the same concentrations, and of
similar DNA length.
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Figure 3.10: CD spectroscopy of altered d-TERRA sequences. CD spec-
tra of oligonucleotides A-I, with Oligo A and Oligo B at 5 µM and oligonucleotides
C-I at 10 µM.
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Figure 3.11: CD spectra of elongated altered d-TERRA sequences. CD
spectra of oligonucleotides 2C-2G at 10 µM.
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Figure 3.12: BLI of elongated altered d-TERRA sequences. BLI per-
formed with HP1α bound to the tip, with addition of each elongated altered
d-TERRA 45 sequence.
3.3 HP1α binds endogenous promoter G4s
Throughout the genome, there are countless G-rich sequences that are capable
of forming G4s. Many of these sequences are found in promoter regions of genes,
suggesting a role in regulation of gene expression.
To test if HP1α binds non-canonical nucleic acid structures which are present
endogenously, a selection of well characterised G-rich promoters and regulatory
sequences were investigated.
Firstly, their conformation was confirmed by CD to test if they indeed formed the
G4s, and if they did, which G4 conformation they were in (confirming topologies
stated in previous publications). All of these endogenous G4s except two were
shown to have parallel conformation, with SRC2 and SRC16 conforming to mostly
anti-parallel topologies (Figure 3.13).
All of these oligonucleotides were then tested for their interaction with HP1α, and
each showed some interaction with HP1α to varying degrees (Figure 3.14). The
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Figure 3.13: CD spectroscopy of endogenous G4s. CD spectra of sequences
from the human genome, known to form G4s, at 10 µM.
three endogenous oligonucleotides with the lowest measured binding with HP1α
were SRC16, SRC2, and cmyc 2. Of these three, two of them are the only anti-
parallel G4s of the selection, showing that the anti-parallel conformation is very
unfavourable to HP1α. The other low binding oligonucleotide was cmyc 2, which
has the parallel G4 topology. However, given that BLI binding signal is dependant
on amount of light being interfered with, the size of the interfering molecule is a
key factor in this. The cmyc 2 sequence was the shortest of all endogenous G4
oligonucleotides to be tested (16 bp), and therefore could be expected to produce
a lower signal. Further to this, despite the signal of low intensity, the binding
of cmyc 2 to HP1α was the most rapid of the endogenous G4s. The BLI signal
increases very sharply compared to the other oligonucleotides, with a binding
pattern similar to TERRA 45’s response curve.
Given this strong preference by HP1α to interact with non-canonical DNA or
RNA G4s, another similar type of non-canonical DNA structure was investigated.
i-Motifs form four stranded nucleic acid structures too, by the binding of pairs of
cytosines (Figure 1.1). Therefore, they are typically formed in C-rich sequences.
Also, given that guanine and cytosine are paired together in DNA, if a G4 was
formed on one strand, an i-motif may form on the other.
44
Figure 3.14: BLI of endogenous G4s. Binding measured between G4 forming
sequences from the human genome, and HP1α bound to the tip, by BLI. Numbers
adjacent to sequence names indicate their length in nucleotides.
Therefore, the C-rich strand of telomeric DNA (C-telomere 45, used as part of
the telomere duplex molecule tested), along with other published, biologically
relevant i-motif forming sequences were explored (Table 2.1).
The folding of i-motifs was first investigated by CD spectroscopy (after first being
annealed in 1xIB7, the buffer used throughout this work but at pH 7 rather than
pH 8) to confirm their folding, which were all shown to form i-motifs (Figure
3.15). Following this, they were tested for their interaction with HP1α by BLI,
by immobilising HP1α on the tip, and immersing in each subsequent i-motif
oligonucleotide. BLI showed no interaction between HP1α and any of the i-motifs
(Figure 3.16), which were of similar lengths to the elongated and endogenous
G4s tested previously. This shows that HP1α has a strong preference for a specific
non-canonical nucleic acid structure that it binds to.
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Figure 3.15: CD spectroscopy of i-motifs. CD spectra of sequences from
the human genome, known to form i-motifs, at 10 µM.
Figure 3.16: BLI of i-motifs. BLI performed with HP1α immobilised on the
tip, and addition of i-motif-forming sequences from the human genome.
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3.4 Discussion
These results show the outstanding specificity of the HP1α protein, and the strong
dependency on only three residues within the hinge of HP1α for this binding to
G4s.
Firstly, TERRA 96 and TERRA 45, both parallel G4s, bind only to the HP1α
paralog. This is a contradiction to the findings of Deng et al. (2009), who show
binding to both HP1α and HP1β through RNA immunoprecipitation of endoge-
nous TERRA. Although slightly more TERRA is immunoprecipitated with HP1α
than with HP1β, the amount immunoprecipitated with HP1β is significant. The
discrepancy between these results could firstly be due to the difference in endoge-
nous TERRA versus commercially produced (TERRA 45) or in vitro transcribed
molecules (TERRA 96). Endogenous TERRA would be of many varying lengths,
and may have complex folding and intermolecular G4 formations. The buffer
used in each of the respective experiments may have affected folding of the G4s,
and also may have caused different charges to be present in the protein, caus-
ing a potentially lower binding affinity between HP1β and TERRA. Secondly,
the experiments performed above, being in vitro, lack the complex mixture of
molecules present in a cell. Therefore, given that HP1β bound TERRA in in
vivo experiments (Deng et al., 2009), this interaction may require additional co-
factors that aren’t present in in vitro BLI experiments, in which only purified
components were tested. Contrary to this, the lack of other molecules present in
these experiments highlights the strength and importance of the binding between
HP1α and TERRA.
A small amount of binding was shown between HP1γ and TERRA 96 in the
experiments performed above, which again contradict Deng et al. (2009), but
again, the differences could be due to in vitro versus in vivo experiments. HP1γ
does function at human telomeres, and is able to bind a component of the shelterin
complex which protects telomere ends (Canudas et al., 2011). TERRA has also
been shown to interact with shelterin components, TRF1 and TRF2 (Deng et al.,
2009), which may indicate a weak interaction between HP1γ and TERRA as part
of this complex.
Each of the TERRA molecules, when tested for binding with the HP1α hinge mu-
tant, HP1α-3KA, showed a severely abrogated response. This shows the charge
of the lysine patch in the hinge domain is essential for this interaction. This is to
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Table 3.1: QGRS sequences found in Widom 601 DNA
Position Length QGRS G-Score
29 28 GGAGACTAGGGAGTAATCCCCTTGGCGG 9
29 28 GGAGACTAGGGAGTAATCCCCTTGGCGG 10
38 30 GGAGTAATCCCCTTGGCGGTTAAAACGCGG 10
52 18 GGCGGTTAAAACGCGGGG 12
52 19 GGCGGTTAAAACGCGGGGG 13
52 19 GGCGGTTAAAACGCGGGGG 11
be as expected, given the affinity of protonated amino acids to bind negatively
charged phosphates in DNA or RNA. What is surprising is that the same lysine-
rich patches are present in both HP1β and HP1γ (Figure 3.3). This implies
that there are other regions of the HP1α hinge contributing to the interaction,
or other domains of HP1α interacting with TERRA.
HP1α has been shown to interact with isolated DNA, used for reconstituting
nucleosomal arrays (Nishibuchi et al., 2014). This DNA is derived from the
Widom 601 sequence, and is commonly used in nucleosomal arrays because of
the high affinity of this DNA for nucleosomes. A 147 bp DNA fragment of the
Widom sequence was tested for putative Quadruplex forming G-Rich Sequences
(QGRS) using QRS Mapper (Kikin et al., 2006). The reverse strand was shown
to have six putative QGRSs, with G-scores ranging from 9-13. The G-score is a
measure of propensity to form G4s, the higher the score, the higher the likelihood
to form a stable G4, with a maximum possible score of 105 (for the extremely
G-rich sequence (G5T)3G5). Despite the low scores, these sequences may still be
able to form G4s, and this could account for the binding by HP1α to this isolated
DNA sequence. In order to test this theory, the DNA may need to be tested by
CD spectroscopy to show if it had indeed formed G4s. If testing long strands
of DNA in which many G4s may form, DMS footprinting may need to be used.
DMS methylates guanine on the N7 position, however, this N7 atom becomes a
hydrogen acceptor when in a G4, but not in normal Watson-Crick base-pairing.
Therefore, when this methylated DNA is subjected to piperidine treatment to
produce double-strand breaks at methylated nucleotides, G4s are preserved and
shown by Polyacrylamide Gel Electrophoresis (PAGE) as a ”footprint” of absent
bands on the gel (Sun and Hurley, 2010).
Of course, parallel G4s may not be the singular DNA structure that HP1α binds
to, but despite a general acceptance of a DNA binding domain there is very little
evidence in the literature, other than the binding to the Widom sequence, that
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shows that HP1α binds DNA in mammalian cells.
Interestingly, there were DNA G4s that appeared to bind HP1α more than
TERRA 45. Oligo B and SRC14 had a much higher binding response in BLI
with HP1α than TERRA 45, despite being shorter in length. SRC3 and bcl2 also
bound HP1α to a higher degree than TERRA 45. What they all have in common,
of course is that they are of parallel G4 topology. However, there are many more
facets to G4 structure. Other distinctions include dimerisation between G4s, and
whether these form through interactions at the bases of G4s, or whether this is
because of bi, tri, or tetra-molecular interactions within the G4 itself. This will
be explored in Section 4.1.
The biologically relevant DNA G4 sequences used in this work were chosen be-
cause they have been previously shown to form G4s, and also because of the
pivotal roles these G4s may have in the regulation of normal and/or cancerous
cells.
The bcl2 sequence used in this study is a 39 nt long fragment derived from a
GC-rich region upstream of the P1 promoter of the gene that codes for bcl-2
(B-cell lymphoma 2). This region has been shown to be ”critically involved” in
regulating expression of the BCL2 gene (Agrawal et al., 2014). The bcl-2 protein
is a pivotal component of the apoptotic pathway, where cells enter programmed
cell death. This is extremely important in order to prevent cancerous growth,
making BCL2 a tumour suppressor gene. The binding of HP1α to the G4 formed
by the BCL2 upstream sequence could influence the expression of this gene. In
the context of treating cancer, if HP1α or another molecule designed to target
bcl-2 expression could up-regulate production of bcl-2 protein in cancerous cells,
this may provide a way to kill tumours.
C-myc is part of the MYC family of genes, which are transcription factors involved
in the regulation of many genes, some of which are responsible for cell prolifera-
tion. They are therefore proto-oncogenes, capable of allowing over-proliferation
of cancer cells. As with bcl2, HP1α or other molecules designed to bind these G4s
could be used to target and regulate the genes that contain specific G4 structures
in their regulatory regions, such as c-myc, relevant to cancer.
C-kit is a receptor tyrosine kinase involved in intracellular signalling, resulting
in its dysregulation being an oncogenic driver of cancer progression. Given its
propensity for forming G4s (Diveshkumar et al., 2016), again, this is a possible
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mechanism of G4-dependant oncogenesis, and potential G4-targeted drug design.
Yet another oncogene, KRAS (Kirsten Rat Sarcoma), has been investigated in
this work. The G4 sequence is within the promoter of the KRAS gene (Cogoi
and Xodo, 2006), potentially regulating transcription of p21RAS, crucial to the
Raf-MAP kinase pathway, which transmits signals that influence cell growth and
apoptosis.
Within the SRC proto-oncogene are numerous G-rich sequences that have been
shown to form G4s (Rodriguez et al., 2012). A selection of these previously
studied sequences were chosen for this work, the locations within the gene and
strand of which are shown in Table A.1. The work that characterised these SRC
G4s found that a G4-binding molecule, pyridostatin, modulated the expression
of SRC and subsequently src protein abundance, affecting the cellular motility
of cancer cells. This shows that molecules capable of binding G4s affect the
expression in vivo, with a measurable response in cancerous phenotype. This
same method could be followed, modulating the HP1α abundance and/or binding
capabilities (expressing HP1α-3KA), and testing the affects this might have on
cancer cell phenotype.
As discussed in Section 3.2, the maxima at 265-270 nm and at 285-290 nm and
minima at 240 nm indicate a group II G4 topology (Karsisiotis et al., 2011), which
are actually ”mostly” anti-parallel structures. Group II G4s possess one propeller
loop (which parallel G4s have), meaning parts of the G4-forming sequence that
link together G-tracts are on the outside of the G4 structure, adjacent to the
quartets (not above or below like lateral and diagonal loops). If the recognition
by HP1α to parallel G4s is through binding to these propeller loops, then it is
possible that group II G4s may exhibit similar binding patterns if they have com-
patible sequences present in propeller loops despite their anti-parallel structure.
Further investigation is needed to determine what HP1α is specifically recognising
in parallel G4 structures, and whether this is binding to sequence-specific motifs
in loops, or whether it is the overall structure of the G4 that is most important.
The i-motifs used in this work were chosen because of their biological relevance,
and the mild conditions under which they can form. The i-motifs chosen were
all used with IB7 in order to facilitate the formation of i-motifs at pH 7 (rather
than at pH 8 in IB). This pH was also chosen because of its cellular relevance,
showing how these structures may form in vivo.
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One of the i-motifs used in this study (Carlos LL3rep) actually forms a ”mini
i-motif” in which two pairs of hemi-protonated cytosines bind the same way as
in an i-motif, but they are then flanked by two tetrads which result from the
association of G:C or G:T base pairs, similar to G4 formation (Mir et al., 2017).
Formation of this structure at 20 ◦C did not show complete formation of the mini
i-motif structure, however when CD spectroscopy was performed at 5 ◦C (Figure
A.5), the spectrum showed the same ellipticities as previously published (Mir
et al., 2017). Given that BLI was performed at room temperature, it is possible
that the mini i-motif was not fully formed, and to test if HP1α does bind this
structure, perhaps BLI needs to be performed at 5 ◦C too, or have the mini
i-motif structure stabilised in some other way.
Upon close inspection of the CD spectra of these i-motif-forming oligonucleotides,
their maxima and minima are not as distinct as would be expected for i-motif
formation. A maximum around 285 nm would be expected, however, under the
conditions used, this peak with positive ellipticity is shifted to the left in most
cases, forming a peak around 275-285 nm. This indicates that the i-motifs may
be slightly unfolded, however, BLI analysis and CD have been performed on the
C-rich telomeric DNA strand at varying pH (Zeraati, 2018). This analysis showed
the same pH shift from 275 nm (at pH 7), to a more folded form at 287 nm (at
pH 6). The binding between this telomeric i-motif and an i-motif-recognising
antibody was then assessed using BLI, and it was found that the pH affected
the binding, but not drastically (association at 10.5 nm, to association at 9 nm).
The BLI experiments in the aforementioned publication were performed using a
oligonucleotide concentration of 200 nM, whereas the BLI experiments carried out
in this work were performed at 500 nM (same volume). If there was slight binding
between the fully formed i-motif structures and HP1α, if it were significant, HP1α
would still likely have bound the folded form, which would be more biologically
relevant.
Another interesting note, is the similarity in structure between anti-parallel G4s
and i-motifs. They both have strands that arrange themselves in opposite direc-
tions, leading to diagonal or lateral loops at the top or bottom of the structures,
whereas parallel G4s possess propeller loops, on the sides of the G4 structure
(Figure 1.1).
Overall, these results show the intricate specificity of HP1α for a subset of G4
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of HP1α and TERRA 45
To elucidate the structural nuances of the Heterochromatin Protein 1α (HP1α)-
telomeric repeat-containing RNA (TERRA) 45 interaction, firstly, the oligomeric
state of the RNA and proteins used in Chapter 3 were investigated.
Oligomeric qualities were investigated using native Polyacrylamide Gel Elec-
trophoresis (PAGE) to separate oligonucleotides, proteins, or complexes while
maintaining secondary structure. Sodium Dodecyl Sulfate (SDS)-PAGE was also
used in order to estimate the molecular weight of denatured cross-linked protein
species to compare with native PAGE results.
Following this, binding affinity was measured using Biolayer Interferometry (BLI),
and corroboration of these results was attempted using Isothermal Titration
Calorimetry (ITC). ITC was used to measure thermodynamic properties of the
interaction. This can be done by adding small, equal amounts of TERRA 45 into
a cell containing HP1α, and measuring the heat being liberated or absorbed as
a result of non-covalent bond redistribution upon binding with each injection of
TERRA 45. The heat change is measured by the amount of power required to
keep the sample cell at the same temperature as the reference cell. This informa-
tion can then be used to calculate the molar ratio of the interaction, the binding
constant of the interaction, and also the enthalpy and entropy of the interaction.
53
Measuring the strength of the binding between HP1α and TERRA 45 gives con-
text to the importance of this interaction, especially in comparison to other in-
teractions that are thought to maintain constitutive heterochromatin, such as the
interaction between the HP1α chromodomain and H3K9me3.
Small-Angel X-ray Scattering (SAXS) was used in this work in order to investi-
gate sizes and flexibility of HP1α and TERRA 45. SAXS has the advantage of
examining the structure of macromolecules in solution. This provides a better
understanding of the structure of the molecule in vivo, as crystalline structures
may not form in the same way in the cell as when packed and crystallised into
an ordered structure. SAXS determines these structural properties through de-
tecting the elastic scattering behaviour of X-rays, diverted at small-angles by
electrons of the molecule of interest. This can then be processed to show aver-
aged particle sizes, shapes, distribution, and surface-to-volume ratios in order to
model the compact or unstructured nature of HP1α and/or TERRA 45.
This chapter will seek to determine the affinity of the HP1α-TERRA interaction,
the oligomeric state of HP1α and TERRA before and after the interaction takes
place, and the structural changes that take place upon binding.
4.1 G-quadruplex oligomerisation
Following on from assessing G4 topology by CD spectroscopy, the ability of G4s
to form higher order structures was assessed by PAGE under native conditions,
preserving G4 structure and oligomerisation ability.
Native PAGE showed that many of the oligonucleotides are present in multiple
forms, perhaps forming many combinations of inter- and intramolecular G4 struc-
tures (Figure 4.1). Of note, some of the oligonucleotides that bind HP1α more
strongly (as shown by BLI) have lower mobility (higher bands) than others. For
example, Oligo B, cmyc2, SRC14, and TERRA 45 all have a strong binding, and
also all appear to form higher order structures that many of the other oligonu-
cleotides do not (repeated native PAGE showing clearer TERRA 45 monomer
and dimer species is shown in Figure A.6).
There is a stark difference between Oligo A and Oligo B, given that their loop
length only differs by one nucleotide. They both possess the parallel G4 topology,
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Figure 4.1: Native PAGE of G4-forming oligonucleotides. A native 20%
PAGE was performed and stained with Stains-All, with Thy45 (labelled T45) used
as a reference for mobility of unstructured DNA, and to visualise bromophenol
blue mobility as the gel was electrophoresed. Topology refers to whether the
oligonucleotide formed parallel G4s (p), anti-parallel G4s (ap), or did not form
G4s (n.a.).
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due to the loop reduction from anti-parallel d-TERRA 45. However, Oligo B has
a band of very low mobility, showing that the loops of the G4 may contribute to
the oligomerisation ability of the molecule, not just the topology.
Another observation from this experiment was that the anti-parallel G4s had
higher mobility than their parallel counterparts. For example, of the short d-
TERRA 45 variants (oligonucleotides C-I), the three that formed anti-parallel
topology (oligonucleotides E, F, and G) also migrated substantially farther through
the PAGE than the others. This stark difference is also present in the compar-
ison of TERRA 45 to its anti-parallel DNA counterpart, where d-TERRA 45
has a much higher mobility, despite being the same number of nucleotides, and
therefore very similar in molecular weight.
4.2 Protein oligomerisation and mobility
When purifying HP1α by SEC, the absorbance at 214 nm and 280 nm of the
primary peak on the chromatogram was at a lower volume than expected (being
released from the SEC column sooner) for a protein with a molecular weight of 25
kDa (Figure A.7). Using a Superdex 75 10/300 GL SEC column, an estimate
of molecular weight at 8.75 mL would be approximately 100 kDa.
In order to determine whether HP1α was in a dimeric, tetrameric, or other
oligomeric state under the conditions being used for experiments in this work,
firstly, a SDS-PAGE was performed.
In order to determine the oligomeric state of HP1α, one must be able to determine
the size of the species formed by the purified protein. In its native form, the
structure of a protein can dramatically affect its mobility through gel, either
in a size exclusion column matrix or native polyacrylamide gel. Therefore, a
cross-linking experiment was performed in order to bind together the proteins
immediately adjacent to each other, and an SDS-PAGE was performed to estimate
the molecular weights of the denatured cross-linked protein.
This technique was firstly performed on varying concentrations of HP1α in order
to optimise the amount of protein needed to visualise all paralogs of HP1 (Figure
4.2). Sizes of protein standards were measured and graphed in order to determine
sizes of HP1α bands (Figure 4.3). Estimations showed that the primary band
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Figure 4.2: Cross-linked HP1α at varying concentrations separated by
SDS-PAGE. Differing amounts of HP1α were cross-linked by formaldehyde, and
separated by SDS-PAGE. The lane denoted with (-) indicates the control sample
in which no formaldehyde was added to HP1α. M indicates marker lanes, with
molecular weight of the protein standards adjacent.
was between 28.4 kDa and 32.8 kDa. Given that these values are overestimated
due to the warping of the gel, this fits with the expected weight of monomeric
his-tagged HP1α at 25.4 kDa (see Section 2.7.1). Another higher distinctive
band was analysed, and its estimated molecular weight was 56.8 kDa, which is
approximately double the expected molecular weight of HP1α, suggesting that
this other dominant species was a dimer. There were also bands higher than this
dimer species, showing that HP1α is forming higher oligomeric states. However,
due to the inaccuracy of measuring bands above 75 kDa on this gel, their sizes
cannot be estimated.
This experiment was then repeated with HP1α-3KA, HP1β, and HP1γ alongside
HP1α. HP1α-3KA showed similar abundances of bands to HP1α, whereas HP1β
and HP1γ showed that far fewer higher order structures were formed (Figure
4.4).
In order to confirm the presence of species expected due to the cross-linking
experiment above, native PAGE was performed on all of the HP1 proteins. This
showed that each WT paralog of HP1 existed as singular species (Figure 4.5),
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Figure 4.3: Standard curve for estimating cross-linked HP1α molecular
weight. The logarithm of each of the molecular weight standards was calculated
and plotted against the retention factor (Rf) of each of the standards bands. The
slope of the line (displayed on the graph) was then used to calculate the molecular
weight of HP1α using its Rf.
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Figure 4.4: Cross-linked HP1 paralogs separated by SDS-PAGE. HP1
paralogs, HP1α, HP1β, and HP1γ, along with mutant HP1α-3KA, were cross-
linked with formaldehyde, and separated by SDS-PAGE. M indicates marker
lanes, with molecular weight of the protein standards adjacent, and ”+” indicates
addition of formaldehyde. This experiment was performed with a less pure sample
preparation than that of other experiments.
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Figure 4.5: Native protein and complex mobility. PAGE performed under
non-denaturing conditions of each HP1 paralog, and HP1α mutant, HP1α-3KA.
Addition of TERRA 45 is indicated by a plus ”+” symbol. Arrows indicate
different mobilities of HP1α on its own (top), and HP1α with addition of TERRA
45 (bottom).
but due to the conditions of a native gel, it is not possible to estimate size
accurately with this, and therefore it is difficult to deduce what oligomeric state
the proteins are in. The mutant, HP1α-3KA however, showed two distinct species
separated by the gel.
In order to see if addition and/or binding of TERRA 45 to HP1α had an effect
on mobility of the protein, the RNA was added to each of the HP1 proteins.
Surprisingly, the complex formed between HP1α and TERRA 45 had a higher
mobility through the native gel than the protein alone (experiment repeat shown
in Figure A.8). This implies that either the protein or the RNA (or both)
change conformation upon binding, becoming more compact, increasing mobility
of the complex. None of the other HP1 proteins had a change in mobility upon
addition of TERRA 45, which is expected given that they have not been shown
to bind strongly.
4.3 Affinity of the HP1α-TERRA interaction
To obtain a measurement for the kinetic properties of binding between HP1α and
TERRA 45, immobilised HP1α was immersed in eight different concentrations
60
Figure 4.6: Titrating TERRA 45 with HP1α. BLI performed with HP1α
immobilised on the tip, and addition of varying concentrations from 25 nM to 1000
nM of TERRA 45. These binding curves were used to calculate the equilibrium
constant of the interaction.
of TERRA 45, and a dissociation equilibrium constant (KD) was obtained using
the multiple binding curves (global fit) from BLI with the BLItz Pro 1.2 software
(Figure 4.6).
The KD for the interaction between HP1α and TERRA 45 was in the nanomolar
range (Association constant, ka = 2.189 x 10
5 (+/- 7.836 x 103) s−1M−1; dissoci-
ation constant, kd = 1.629 x 10
−2 (+/- 4.446 x 10−4) s−1; equilibrium constant,
KD = 74 nM), showing that there was significant binding between HP1α and
TERRA 45.
The experiment above was also performed with TERRA 96 in place of TERRA 45
(although with fewer data points, Figure A.9). The global fit of multiple binding
curves produced another nanomolar KD (Association constant, ka = 1.593 x 10
5
(+/- 8.64 x 103) s−1M−1; dissociation constant, kd = 3.96 x 10
−4 (+/- 3.911 x
10−5) s−1; equilibrium constant, KD = 2.5 nM), showing a stronger binding to
TERRA 96 than to TERRA 45.
Although BLI is capable of outputting reasonably accurate KD data (Laigre
61
et al., 2018), it does not provide a complete picture of the thermodynamics of
the interaction. ITC, instead of using changes in light to infer an interaction
between species, uses changes in temperature. The change in temperature is
directly linked to the binding or dissociation of molecules.
Following dialysis of TERRA 45 and HP1α, ITC was performed by injecting 2
µL (19 times) of 225 µM TERRA 45 into 280 µL of 23.7 µM HP1α. This yielded
results shown in Figure 4.7, where it appears that within the first 2 µL injection,
50% of the binding sites on HP1α have already been bound by TERRA 45.
This yielded data showing that the interaction had a binding constant, K, of 1
x 105 M−1. This is the reciprocal of the equilibrium constant, KD, calculated
by the BLItz software (see Figure A.10). Therefore, for comparison with BLI
results, the reciprocal of K was calculated to give a KD of 9.35 x 10
−6 M. This
value is unreliable, due to the incomplete sigmoidal curve present in this ITC
attempt, the slope of which is used to calculate the binding constant, therefore
ITC was repeated.
With attempt 2, HP1α concentration was increased (to 33 µM), and 1 µL in-
jections (39 times) were used instead of 2 µL injections, so that the amount of
TERRA 45 added each injection would be half of the amount as in attempt 1.
Attempt 2 also appeared to be unsuccessful in yielding a complete sigmoidal curve
(Figure 4.8), again showing apparent saturation of 50% of the binding sites on
HP1α.
ITC was attempted a third time, again, increasing the concentration of HP1α
(to 44 µM), and keeping with 1 µL injections, decreasing the concentration of
TERRA 45 to 109 µM.
ITC attempt 3 was also unsuccessful, this time yielding nothing resembling a
sigmoidal curve (Figure 4.9), and low concentration of TERRA 45 compromised
the signal to noise ratio.
It was then concluded that, due to the apparent complex nature of the HP1α-
TERRA 45 interaction, given the mixed species present in TERRA 45, perhaps
an accurate ITC measurement cannot be made until more is known about the
specificity of the binding of HP1α to isolated monomer and dimer.
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Figure 4.7: ITC attempt 1. ITC of HP1α and TERRA 45. The top graph
displays raw data after the integration baseline has been subtracted. The bottom
graph displays the normalised integration data. Lack of data at low molar ratio
of TERRA 45 : HP1α limits interpretation to ∆H <0, and ∆S <0.
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Figure 4.8: ITC attempt 2. ITC of HP1α and TERRA 45, with increased
HP1α concentration, and decreased TERRA 45 injection volume. The top graph
displays raw data after the integration baseline has been subtracted. The bottom
graph displays the normalised integration data. Lack of data at low molar ratio
of TERRA 45 : HP1α limits interpretation to ∆H <0, and ∆S <0.
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Figure 4.9: ITC attempt 3. ITC of HP1α and TERRA 45 with increased
HP1α concentration, and decreased TERRA 45 concentration. The top graph
displays raw data after the integration baseline has been subtracted. The bottom
graph displays the normalised integration data. Lack of data at low molar ratio
of TERRA 45 : HP1α limits interpretation to ∆H <0, and ∆S <0.
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4.4 Small-angle X-ray scattering of HP1α and
TERRA 45
SAXS was performed on each of the individual components of the interaction,
HP1α and TERRA 45, and then also the complex of which they form. SAXS was
also performed on HP1α-3KA in order to compare structural differences between
the WT and mutant.
As shown by the double log graph (Figure 4.10), and the Kratky plot (Figure
4.11), TERRA 45 is in a more compact, ordered state. This is illustrated by the
more horizontal line in the double log graph, and the parabolic curve shown in
the Kratky plot.
By stark contrast, both HP1α and HP1α-3KA show the exact opposite, with a
flexible, disordered state shown in the double log and Kratky plots.
The complex of HP1α and TERRA 45, shown on the Kratky plot, does appear
to be slightly ordered, whereby the end of the curve does come back to around 0
(whereas the HP1α and HP1α-3KA curves do not return to 0). This may suggest
a more compact structure of the complex compared with just HP1α alone.
TERRA 45 showed a small radius of gyration (Rg) value (Table 4.1), which is
the quadratic mean of distances to the centre of the mass weighted by the contrast
of electron density. This means that the mass of TERRA 45 takes up a relatively
small space, meaning it is in a compact structure.
HP1α and HP1α-3KA each showed large Rg values relative to their molecular
weights, with HP1α-3KA possessing a slightly more compact structure shown by
the smaller Rg value.
The Rg of the complex was approximately the sum of the Rg values of TERRA
45 and HP1α.
Molecular weight estimations showed that the predominant species analysed of
TERRA 45 was approximately 12,025 Da (Table 4.2), similar to the expected
monomeric molecular weight of 14,814 Da. HP1α and HP1α-3KA molecular
weight estimates were exactly the same at 53,150 kDa, approximately double
the size of the monomeric form so most likely dimeric protein. The Rg values
calculated from the distance distribution analysis also match up with the Rg
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Figure 4.10: Raw scattering data plotted in log form. Raw SEC-SAXS
scattering data of TERRA 45, HP1α, HP1α-3KA, and the complex between
TERRA 45 and HP1α, plotted as the log of I (intensity), versus the log of q
(momentum transfer).
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Figure 4.11: Raw scattering data presented as a Kratky plot. Raw
SEC-SAXS scattering data of TERRA 45, HP1α, HP1α-3KA, and the complex
between TERRA 45 and HP1α, plotted as a Kratky plot.
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Table 4.1: SAXS data derived from Guinier plots (shown in appendix)
Name C (µM) Rg (+/-) I(0) Guinier range
TERRA 45 200 15.43 +/- 0.27 0.0054 +/- 5.6e-05 5-100
HP1α 200 41.65 +/- 1.37 0.013 +/- 0.00029 2-27
HP1α-3KA 200 38.97 +/- 0.91 0.013 +/- 0.00021 1-30
Complex 100 64.75 +/- 3.12 0.016 +/- 0.00066 1-12
Table 4.2: SAXS data derived from molecular weight and distance distribution
analysis
Name MW estimate Rg Dmax Porod Porod volume
TERRA 45 12025 15.66 56.95 (5-480) 16600 922.18 (5-861)
HP1α 53150 44.47 164 (2-450) 141000 1200 (2-826)
HP1α-3KA 53150 42.48 162.05 (4-480) 118000 2830 (1-826)
Complex 326450 70.74 244.10 (2-350) 735000 2710 (1-826)
values calculated by Guinier plot.
The molecular weight estimate of the complex was 326,450 Da, much larger than
expected. This could mean that the complex has a more complicated stoichiome-
try than anticipated, or this structure is a large aggregate of protein or complexes.
The Rg value is also agreeable with the Rg value found by Guinier analysis.
4.5 Discussion
When purifying HP1α for downstream applications, it was noted that on the
SEC chromatogram (Figure A.7) the predominant peak (later confirmed to be
HP1α by western blotting, Figure A.15) had a higher molecular weight estimate
than expected. In the literature, many assume HP1α to be a dimer (Hinde et al.,
2015), capable of homo-dimerisation with itself, or hetero-dimerisation with other
HP1 paralogs (Ye et al., 1997). Others have stated the possibility of HP1 proteins
forming higher order structures dependent on their PTMs (Brasher et al., 2000).
In the cross-linking experiments with HP1 proteins, higher bands on the gel indi-
cated higher order structures such as trimers or tetramers being formed (Figure
4.2, Figure 4.4). Formaldehyde was used as the cross-linking agent in this
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case, which is commonly used in immunoprecipitation experiments pertaining to
chromatin interactions. Formaldehyde is used because of its small size, forming
links between molecules only approximately 2 Å apart. However, its behaviour is
highly dictated by its chemical environment, including pH and temperature. It
is possible that the interactions shown in these experiments could be non-specific
cross-linking of closely associating proteins, regardless of actual interaction be-
tween them.
It was thought that the native PAGE of the HP1 proteins might support the
results shown in the cross-linking experiments; however, they somewhat contra-
dicted one another. Each of the WT HP1 paralogs showed a singular species of
indeterminate molecular weight (Figure 4.5). This supports what was stated
above, in that the cross-links formed may have been proteins in close proximity
rather than actually interacting together. Interestingly though, the HP1α-3KA
protein formed two distinct species. The fact that changing only three amino
acids, also shown to be the determinant of nucleic acid binding ability, also
changed the ability of the protein to solely form the higher order structure is
significant.
The higher band formed by HP1α-3KA seems more similar to the migration of
the HP1α WT protein, but it also has a band of higher migration. This indicates
that the band which migrates slower is perhaps a dimer, while the band which
migrates faster may be a monomer. As the higher band of HP1α-3KA may be
a dimer, given it has a similar mobility to the singular HP1α band, this may
also be a dimer, assuming that the HP1α-3KA bands are not dimer and tetramer
instead.
Recent work has shown that the apparent dimerisation of HP1α is not solely
through the CSD as previously thought. Larson et al. (2017) showed by cross-
linking MS of HP1α that the majority of links between HP1α homodimers was
actually through the C-terminal extension binding with residues in the hinge of
HP1α. Upon close inspection of their data, these links include the lysine residues
at positions around 104-106, which have been modified in the HP1α-3KA mutant.
The stunted ability of HP1α-3KA to form the higher order structure that WT
HP1α can may actually be a determinant of G4 binding ability, given the split of
the protein at the higher order state and lower order state, and the incomplete
abolishment of binding between HP1α-3KA and TERRA.
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It is also noteworthy that HP1β has vastly higher mobility through the gel com-
pared with the other HP1 paralogs, despite their similarity in molecular weight
and sequence. It appears to migrate at a similar rate to the lower band of HP1α-
3KA, indicating that it may only be present as a monomer, supporting the notion
that it may be dimerisation ability that dictates HP1 binding to G4s. In contrast
to this, is that HP1γ migrates similarly to HP1α, possibly forming a dimer. The
amino acid sequences of the HP1 paralogs used in this work are shown in Figure
A.3, which shows that the HP1γ sequence, compared to the others, has large
gaps where HP1α does not, including a six residue region in the hinge. It would
be interesting to see if these significant sequence differences are the regions which
are also partly responsible for the binding capabilities of HP1α to G4s.
The gel electrophoresis experiments performed in this work gave an inconclu-
sive result as to exactly what state each of the HP1 proteins was in (however
it is likely to be the dimer/monomer scenario discussed above), and the large
molecular weight estimates of HP1α could be due to its intrinsically disordered
state and flexibility. Furthermore, these in vitro experiments may not be fully
representative of how HP1α acts inside of the cell, showing the need for further
investigation into the state of HP1α with in vivo experiments.
Native PAGE was also performed on the G4s used in this work (Figure 4.1).
As stated in Section 4.1, the bands of lower mobility (higher position on the
gel) correlated with binding ability to HP1α, and bands of higher mobility (lower
position on the gel) were of anti-parallel G4 topology, which HP1α does not bind
to significantly.
In vivo, TERRA has been shown to exist at lengths up to 9000 bp (Azzalin
et al., 2007), possessing assumably very complex intramolecular G4 interactions.
It is possible that the parallel higher order structures shown on the gel that bind
HP1α are more similar to the complex structure of TERRA in the cell, accounting
for HP1α’s preference for these oligonucleotides. More work needs to be done to
elucidate the in vivo structures of G4s shown to interact with proteins like HP1α,
because in isolated in vitro experiments, the behaviour and state of the G4s they
interact with are much more complex within the cell. For example, G4s can
be formed with four strands from different molecules, and/or can be DNA:RNA
hybrids (Zhang et al., 2014). The complexity of the G4s formed in the cell would
be extremely hard to replicate, again, calling for more interaction data sought
from in vivo experiments.
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With the results obtained from the native PAGE in this study, the determination
of molecular weights is not reliable, due to the secondary structure influence.
There is a need to implement methods such as mass spectrometry (MS) in order
to accurately measure the native mass and dimerisation ability of the protein and
oligonucleotides.
The BLItz Pro software calculates KD values by fitting binding and dissociation
curves to the data provided, and using these curves, calculates the association rate
constant (ka) and dissociation rate constant (kd) of the interaction. The ka and kd
are then used to calculate the KD, which indicates the concentration of oligonu-
cleotide at which 50% of protein binding sites are occupied at equilibrium, or
the concentration at which the number of protein molecules with oligonucleotide
bound equals the number of protein molecules without oligonucleotide bound. In
these calculations, only the concentration of oligonucleotide is taken into account,
and the binding is assumed to be 1:1.
The binding strength between HP1α and TERRA 45 was shown to be 74 nM
measured by BLI (Figure 4.6), meaning that only 74 nM of RNA was required
to occupy 50% of the binding sites of protein bound (4 µL of 100 µg/mL pro-
tein) to the tip. This nanomolar range KD is much stronger than the binding
shown between the chromodomain of HP1α and H3K9me3, which suggests a
very high significance of this interaction. For a long time, the simple model
of heterochromatin formation has been that HP1α binds H3K9me3, recruiting
methyltransferases to methylate more H3K9, resulting in spreading of condensed
heterochromatin. This model is basic, and like with many things that occur in
a living cell, the reality is that it’s very complex. The finding that HP1α binds
TERRA, a G4 present in a region of constitutive heterochromatin and is tran-
scribed from, and present at telomeres, strongly suggests a role for G4-dependent
recruitment of HP1α to regions of heterochromatin.
Due to BLI technology being a very niche and novel technique and the simplicity
of the binding model that it computes, the significance of this interaction needs
to be confirmed using an alternative technique, which is why ITC was used in an
attempt to measure the thermodynamic properties of the interaction.
For an accurate KD to be determined using ITC, a typical sigmoidal curve is
used to estimate the point at which half of the binding sites on the protein
are occupied by RNA. In order to accurately estimate this point, it is best if the
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whole sigmoidal curve is visible in order to measure the slope and inflection point.
This could not be achieved during these attempts to test the HP1α-TERRA 45
interaction (Figure 4.7, Figure 4.8, Figure 4.9).
Wiseman et al. (1989) give an equation to calculate a c-value (sample concentra-
tion, affinity-related parameter), which should be between 1 and 1000 (preferably
10 to 500) for optimal ITC results. The c-values given by the HP1α concen-
trations and KD (calculated by BLI) assuming a 1:1 interaction are 338, 471,
and 628 for attempts 1, 2, and 3, respectively. These are all within the recom-
mended c-value range, which would typically give reliable results, assuming the
concentration of RNA is high enough. Therefore, this would indicate that the
HP1α-TERRA 45 interaction is more complex than originally thought, thwarting
ITC attempts.
Given the above results investigating the oligomerisation of HP1α, which is most
likely a dimer, and TERRA 45, which is present as both a dimer and a monomer,
this interaction may be too complex to study using ITC. This notion is also
supported by the large molecular weight estimate of the complex found by SAXS
(Table 4.2). The dimer and monomer of TERRA 45 either need to be isolated
and stabilised in those forms to show which species HP1α binds to, or substrates
mimicking these monomers and dimers need to be constructed for this purpose.
Only then will ITC be able to determine the thermodynamic properties of the
interaction, where each species is homogeneous.
The SAXS data obtained for these experiments was produced using SEC-SAXS,
whereby sample is exposed to the X-ray beam following elution by the Co-flow
system, separating species based on native size. Because of this, data must first
be selected from a chromatogram, separating out the appropriate peak to study.
In each case, data were selected of the predominant peak, with stable Rg values
(example shown in Figure A.16). In cases such as the complex formation,
protein and complex being eluted at similar times by SEC made it difficult to
isolate signal originating from the complex alone, leading to possibly skewed
results. In future, a column capable of separating out these distinct species will
need to be taken to and fitted onto the SEC-SAXS system in order to properly
isolate complex signal.
The SAXS data obtained on TERRA 45 show it is a relatively small, very ordered
structure (Figure 4.11, Table 4.1). This is as expected for a molecule formed
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into a G4, which thermodynamically is very stable.
SAXS performed on HP1α and HP1α-3KA showed very disordered structures, of
which HP1α-3KA may be slightly more ordered. This was also expected, due to
literature alluding to an ”unstructured hinge domain”, and the total lack of crys-
tal structures of HP1α (only the chromodomain and CSD have been crystallised).
In future SAXS experiments, to more accurately determine the oligomeric state,
and also the formation of aggregates, a dilution series of HP1α should be per-
formed. This could also determine if there are other significant concentration
effects, such as inter-particle interactions.
Previous SAXS data has been obtained on HP1α at a similar concentration,
which showed that a WT HP1α dimer had a Dmax of 130 Å, however, when
phosphorylated on its N-terminal extension had a Dmax of 220 Å. The Dmax
obtained in this work was 164 Å (Table 4.2), in between the values obtained by
Larson et al. (2017). Again, this discrepancy could be due to PTMs deposited on
HP1α during its bacterial expression, highlighting the need for MS to be done to
determine presence of PTMs.
The SAXS data measured on the complex was at a lower concentration to that
of its components alone. Therefore, the signal obtained was weaker than that of
HP1α and TERRA 45. If performed at a higher concentration, this may have
made it easier to determine more accurately how ordered the complex appeared
to be on the Kratky plot.
Overall, these results show the complexity of the HP1α-TERRA interaction, the
challenges that are faced in a unique interaction with many possible states of bind-
ing partners. This shows the requirement for further in vitro work to elucidate
the mechanism by which HP1α and TERRA bind, and also in vivo work, putting




Conclusions and Future Work
Firstly, this work showed that the binding to parallel G-quadruplex (G4) telom-
eric repeat-containing RNA (TERRA) molecules was exclusive to Heterochro-
matin Protein 1α (HP1α), the primary HP1 paralog associated with constitutive
heterochromatin formation. Upon mutation of three residues in the hinge region
of HP1α from lysines to alanines, which have been shown to bind RNA and sub-
sequently target HP1 to centromeres (Maison et al., 2011), binding to TERRA
was extremely abrogated.
It was found that HP1α did not bind telomeric DNA, which formed anti-parallel
G4 topology. Upon modifying the sequence of the telomeric DNA in order to
change its topology, a strong preference for only parallel G4 structures was shown
by HP1α.
HP1α was also able to bind a range of DNA G4s, with preference for parallel
topology, that are formed in regulatory regions of genes associated with cancer,
and yet HP1α did not show any binding to i-motif structures of endogenous
sequence, tRNA, duplex DNA, or unstructured DNA.
It was then found that the binding between HP1α and TERRA 45 was 74 nM,
and binding between HP1α and TERRA 96 was 2.5 nM, both of these values
showing strong binding, however, this was unable to be confirmed by isothermal
titration calorimetry (ITC).
This work showed a pattern of binding between HP1α and parallel G4 oligonu-
cleotides capable of forming higher order structures, and also showed that the
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complex formed between HP1α and TERRA 45 has higher mobility, and is pos-
sibly more rigid and compact than just HP1α alone.
This characterisation of the HP1α-TERRA interaction highlights its intricacy
and specificity, owing to its importance in heterochromatin formation. This work
has led to a new model of heterochromatin formation by lncRNA recruitment at
the telomeres (Figure 5.1), whereby TERRA is localised to telomeres, and forms
G4s that provide a specific docking site for HP1α to bind through its unstructured
hinge region. This provides unique specificity to heterochromatin formation at
telomeres, a vulnerable region of the genome.
The next steps in this research include the following. Performing mass spec-
trometry (MS) under native conditions with whole protein would confirm the
oligomeric state of HP1α. MS of digested HP1α would also determine if bacterial
expression had deposited any PTMs, potentially affecting the binding between
HP1α and TERRA. Further to this, other PTMs from the literature, for example
phosphorylation (on N-terminal serine residues, Hiragami-Hamada et al. (2011))
and sumoylation (on the hinge, (Maison et al., 2011) of specific residues would
need to be pursued in order to test if these have any effect on the HP1α-TERRA
interaction, potentially altering the targeting of HP1α if binding to TERRA is
abrogated by them.
Confirmation of the effect of the HP1α-TERRA interaction on chromatin conden-
sation then needs to be done through the studies of nucleosomal arrays. HP1α
and TERRA could be tested for their requirement for the formation of hete-
rochromatin through scrutinising nucleosomal arrays through analytical ultra-
centrifugation, SAXS, and SANS. The compaction of the nucleosomal array can
be assessed using SAXS and SANS, and the density of the array can be assessed
using analytical ultracentrifugation.
Following all of these in vitro techniques, the consequences of this interaction
need to be confirmed in vivo. This could firstly be done using induced expression
of tagged HP1α or HP1α-3KA (or other mutants) in mammalian cell lines. A
ChIP assay could be performed, whereby tagged HP1α and associated RNA or
DNA will be immunoprecipitated, and co-immunoprecipitated G4s can be de-
tected using commercially available G4 antibodies. Further to this, the structure
and proteins present on telomeres can be assessed by confocal microscopy (using
antibodies for HP1α and other proteins of interest) using the cell lines discussed
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above. Telomere structure can be assessed in WT and mutant HP1α cell lines,
and co-localisation of TERRA or other telomeric associated molecules may be
assessed using immunofluorescence.
The work discussed in this thesis, together with the experiments mentioned above,
provide a methodology to study the role of TERRA and HP1α in the formation
and protection of telomeric heterochromatin. This interaction is pivotal to un-
derstanding telomere protection and regulation, while also bringing the function
of non-canonical nucleic acid structures in the genome into light.
High affinity binding between a pivotal chromatin regulator and a G4 molecule
has potential in drug design, relating to G4s associated with cancer, such as the
endogenous oligonucleotides used in this work. The interaction between HP1α
and TERRA is also a large target for drug design, given the roles of TERRA in
telomerase function and ALT in regulating telomere length in cancer cells.
The central dogma of molecular biology dictates that DNA and subsequent tran-
scription into RNA are the only functions of nucleic acids, however, following
the discoveries of non-coding RNAs in gene regulation, the roles of these highly
structured RNAs are now an extra level to our understanding of gene regulation
and the epigenome. And now, this work can further transform our understanding
of biology, showing formerly overlooked non-canonical nucleic acid structures are
potentially crucial to the function our genome.
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Figure 5.1: Model of TERRA-dependent targeting of HP1α to telom-
eres. TERRA is present at the telomeres, either through its nascent transcrip-
tion, or the formation of DNA:RNA hybrids with the telomeric repeats. The
formation of G4s by TERRA allows for HP1α to be recruited, then binding
H3K9me3 and subsequently dimerising in order to compact chromatin. Blue
strands indicate DNA, red indicates RNA.
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Table A.1: SRC G4 locations







Figure A.1: Expression plasmid for HP1 proteins. Vector use for expres-
sion of HP1 isoform and mutant proteins. Shown is the HP1α expression plasmid,
which contains the cDNA from Mus musculus HP1a. All HP1 protein used in
this body of work has been produced with this plasmid, with variations in the
cDNA sequence corresponding to each HP1 protein.
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Figure A.2: SEC purification. Fractions of 2 µL from SEC with a Su-
perdex 200 10/300 GL column electrophoresed on a 12% SDS-PAGE, stained
with Coomassie. Fractions 34 to 56 were pooled.
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Figure A.3: His-HP1 amino acid sequences. Alignment of the his-tagged
HP1 protein amino acid sequences used in this research, aligned using CLUSTAL
O(1.2.4) multiple sequence alignment (Sievers et al., 2011). The numbers above
the sequence indicate the amino acid position of the first and last hinge residue in
the HP1α amino acid sequence. The black line indicates the three lysine residues
in HP1α that were exchanged for alanine residues in the HP1α-3KA mutant. An
”*” (asterisk) indicates positions which have a single, fully conserved residue. A
”:” (colon) symbol indicates conservation between groups of residues with strongly
similar properties. A ”.” (period) indicates conservation between groups of weakly
similar residues.
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Figure A.4: Binding of HP1α to Oligos A-I. BLI performed with HP1α
immobilised on a biosensor, with addition of Oligos A-I. Shorter oligonucleotides
(C-I), do not produce significant signal, indicating that they may be too small to
be detected by BLI.
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Figure A.5: CD spectra of CarlosLL3 at differing temperatures. CD
performed on the CarlosLL3 i-motif oligonucleotide at 20 ◦C and 5 ◦C, at 10 µM.
Figure A.6: Repeat of native oligonucleotide experiment. A native PAGE
performed on endogenous G4s, TERRA 45, d-TERRA 45, Oligo 2C, and Oligo
2D. Of note, are the two distinctive species formed by TERRA 45.
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Figure A.7: HP1α chromatogram following size exclusion chromatog-
raphy. Chromatogram showing HP1α elution from a Superdex 75 10/300 GL
column.
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Figure A.8: Repeat of native protein experiment. Native PAGE per-
formed on HP1 isoforms and mutant protein, with addition of TERRA 45 to
HP1α.
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Figure A.9: Titrating TERRA 96 with HP1α. BLI performed with HP1α
immobilised on the tip, and addition of varying concentrations of TERRA 96.
These binding curves were used to calculate the equilibrium constant of the in-
teraction. This data is not reliable, due to the differences in binding at the
same concentration of TERRA 96, and not a clear trend in concentration versus
binding.
Figure A.10: Equations showing how KD and K are calculated. a) The
equilibrium constant, KD (in this equation shown as Kd) is calculated by koff
(kd in BLItz analysis) divided by kon (ka in BLItz analysis), as performed by the
BLItz software, in units M. b) The binding constant, K, calculated as shown, the
opposite of as used in BLItz analysis, yielding units of M−1. ”R” refers to the
receptor concentration, and ”L” refers to the ligand.
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Figure A.11: Guinier plot of TERRA 45. The red line indicates a line of best fit
(which is then used to calculate Rg values shown in (Table 4.1), and the green
line indicates the position of data points above and below the line of best fit.
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Figure A.12: Guinier plot of HP1α. The red line indicates a line of best fit
(which is then used to calculate Rg values shown in (Table 4.1), and the green
line indicates the position of data points above and below the line of best fit.
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Figure A.13: Guinier plot of HP1α-3KA. The red line indicates a line of best fit
(which is then used to calculate Rg values shown in (Table 4.1), and the green
line indicates the position of data points above and below the line of best fit.
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Figure A.14: Guinier plot of complex. The red line indicates a line of best fit
(which is then used to calculate Rg values shown in (Table 4.1), and the green
line indicates the position of data points above and below the line of best fit.
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Figure A.15: Western blot of HP1α. Western blot showing the soluble frac-
tion of an E. coli cell lysate, as well as induced (IPTG addition) and uninduced
cell lysates in order to confirm the protein expressed was indeed HP1α, using
HP1α antibody (#2616, Cell Signaling Technology, USA). Western blotting was
performed by Imogen Dumville.
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Figure A.16: Selection and subtraction of TERRA 45 using Chromixs
for SEC-SAXS data processing. Chromatogram showing the average inten-
sity of SAXS signal as TERRA 45 is eluted using SEC. a) Before data has been
processed, showing widely differing Rg values. b) Data selection, showing a range
of Rg values which are constant in the area of the chromatogram that corresponds
to TERRA 45 elution.
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